| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | NCOA6 SREBF1 KLF14 CHD4 SMARCAD1 NDN SAMD7 MBD6 CIC PWWP2A PYGO2 ATXN1 TOX3 NR1H2 SFPQ ARID3A EP400 FOXN4 CHD7 PHC2 TGIF1 EPOP BRD4 SMARCA2 AUTS2 ANKRD17 ARID3C RERE EP300 VCX CUX1 | 5.27e-09 | 739 | 253 | 31 | GO:0003682 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L NCOA6 PNKP MAP1A NACA CHD4 BCL9 MAGI2 TSC22D1 FAF2 AP1G1 TOX3 SYN1 DGCR8 EPN1 MRTFA RBPMS ABI1 MAGED1 ARID3A AKIRIN1 ANK3 GAS2L3 GRB10 MED15 SRRT ZBTB32 SETD5 ATF7IP BRD4 SMARCA2 SHARPIN RERE SPEN EP300 CUX1 | 5.96e-07 | 1160 | 253 | 36 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L NCOA6 PNKP MAP1A NACA CHD4 BCL9 MAGI2 TSC22D1 FAF2 AP1G1 TOX3 SYN1 MICAL3 DGCR8 EPN1 MRTFA RBPMS ABI1 MAGED1 ARID3A AKIRIN1 ANK3 GAS2L3 GRB10 MED15 SRRT ZBTB32 SETD5 ATF7IP BRD4 SMARCA2 SHARPIN OTUD4 RERE SPEN EP300 CUX1 | 3.30e-06 | 1356 | 253 | 38 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L NCOA6 NACA CHD4 BCL9 TSC22D1 TOX3 MRTFA RBPMS MAGED1 ARID3A AKIRIN1 MED15 ZBTB32 SETD5 ATF7IP BRD4 SMARCA2 RERE SPEN EP300 | 1.06e-05 | 562 | 253 | 21 | GO:0003712 |
| GeneOntologyMolecularFunction | SH3 domain binding | CTTNBP2 SH3BP1 SYNJ1 ESPN MICAL1 ABI1 PDCD6IP ARHGAP17 BCAR1 PRRT2 | 1.46e-05 | 143 | 253 | 10 | GO:0017124 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.82e-05 | 37 | 253 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NCOA6 NACA BCL9 TSC22D1 TOX3 MRTFA RBPMS MAGED1 BRD4 SMARCA2 RERE EP300 | 1.39e-04 | 303 | 253 | 13 | GO:0003713 |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 2.19e-04 | 24 | 253 | 4 | GO:0008093 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 3.08e-04 | 11 | 253 | 3 | GO:0099122 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOA6 CTTNBP2 SH3BP1 LILRB1 SCAF1 WIZ SYNJ1 ATXN1 SESN2 PLXNB3 MRTFA ESPN MPP2 MICAL1 ABI1 PDCD6IP ARHGAP17 BCAR1 PRRT2 SHROOM2 ATXN1L ARHGAP5 SNTA1 SON | 3.33e-04 | 875 | 253 | 24 | GO:0019904 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 4.22e-04 | 140 | 253 | 8 | GO:0001221 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 8.17e-04 | 15 | 253 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TGIF2 ZNF142 FOXB2 SREBF1 KLF14 HSFY1 SAMD7 RREB1 CIC HOXA5 HOXB2 ZBTB7A WIZ KLF5 NR1H2 ZNF579 ATMIN ATF7 FOXN4 CC2D1B E2F2 MLXIP TGIF1 ZBTB32 ZFHX4 NKX2-4 MTF1 BARHL2 YLPM1 ARID3C EPAS1 CUX1 | 9.97e-04 | 1412 | 253 | 32 | GO:0000981 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TET2 BCL9L NCOA6 ZNF142 CDK12 NACA SREBF1 KLF14 NDN RREB1 BCL9 LILRB1 HOXA5 PWWP2A HOXB2 TSC22D1 ATXN1 KLF5 TOX3 NR1H2 NOTCH3 MRTFA IQCE ATMIN ATF7 SFPQ ARID3A AKIRIN1 FOXN4 CRTC1 E2F2 CHD7 MLXIP MED15 MTF1 BRD4 BARHL2 ZNF335 SMARCA2 AUTS2 ARID3C EP300 EPAS1 | 9.50e-09 | 1390 | 248 | 43 | GO:0045944 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | CTTNBP2 SH3BP1 OBSCN TSC1 FMNL2 AMOT AMOTL1 FGD1 MICAL3 MYO18B MRTFA ARAP1 ESPN MICAL1 ABI1 PDCD6IP GAS2L3 PCLO MINK1 ARHGAP17 BCAR1 SHROOM2 NUAK2 LATS1 TENM1 AUTS2 FMN2 EP300 | 4.68e-07 | 803 | 248 | 28 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TGIF2 NACA SREBF1 CHD4 NDN SAMD7 RREB1 PTCH1 CIC SCAF4 ZBTB7A ZNF469 MAGED4 ATXN1 KLF5 NR1H2 MAGEC1 NOTCH3 ATF7 SFPQ MAGED1 CC2D1B ATXN1L TGIF1 ZBTB32 ATF7IP YLPM1 SMARCA2 SPEN EP300 EPAS1 CUX1 | 1.38e-06 | 1053 | 248 | 32 | GO:0000122 |
| GeneOntologyBiologicalProcess | actin filament-based process | CTTNBP2 SH3BP1 OBSCN TSC1 FMNL2 AMOT AMOTL1 FGD1 MICAL3 MYO18B MRTFA ARAP1 ESPN MICAL1 ABI1 PDCD6IP GAS2L3 PCLO MINK1 ARHGAP17 BCAR1 SHROOM2 NUAK2 LATS1 TENM1 AUTS2 FMN2 SNTA1 EP300 | 1.85e-06 | 912 | 248 | 29 | GO:0030029 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 BCL9L MAP1A MAP2 NDN RREB1 PTCH1 TTC3 PRAG1 FMNL2 HMCN2 NBEAL2 FGD1 ROBO3 NYAP1 PLXNB3 NOTCH3 ARAP1 ABI1 ANK3 JADE2 MINK1 SHROOM2 COL18A1 LATS1 BARHL2 ZNF335 EIF4G2 AUTS2 PALM3 RERE EP300 ZMYM3 CUX1 | 2.65e-06 | 1194 | 248 | 34 | GO:0000902 |
| GeneOntologyBiologicalProcess | head development | NCOA6 PEX13 PFAS TSC1 VCX3B PTCH1 CIC HOXB2 PYGO2 ATXN1 SEC16A SECISBP2 NOTCH3 MRTFA VCX2 VCX3A MINK1 CHD7 XRCC1 SHROOM2 ATXN1L VCY AATK ZNF335 RERE HYDIN EP300 VCX | 6.34e-06 | 919 | 248 | 28 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TGIF2 NACA SREBF1 CHD4 NDN SAMD7 RREB1 PTCH1 CIC SCAF4 TNFRSF4 ZBTB7A ZNF469 MAGED4 ATXN1 KLF5 NR1H2 MAGEC1 NOTCH3 ATF7 SFPQ MAGED1 CC2D1B ATXN1L PHC2 TGIF1 ZBTB32 SETD5 ATF7IP YLPM1 SMARCA2 RERE SPEN EP300 EPAS1 CUX1 | 1.26e-05 | 1399 | 248 | 36 | GO:0045892 |
| GeneOntologyBiologicalProcess | brain development | NCOA6 PEX13 TSC1 VCX3B PTCH1 CIC HOXB2 PYGO2 ATXN1 SEC16A SECISBP2 NOTCH3 MRTFA VCX2 VCX3A MINK1 CHD7 XRCC1 SHROOM2 ATXN1L VCY AATK ZNF335 RERE HYDIN VCX | 1.55e-05 | 859 | 248 | 26 | GO:0007420 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TGIF2 NACA SREBF1 CHD4 NDN SAMD7 RREB1 PTCH1 CIC SCAF4 TNFRSF4 ZBTB7A ZNF469 MAGED4 ATXN1 KLF5 NR1H2 MAGEC1 NOTCH3 ATF7 SFPQ MAGED1 CC2D1B ATXN1L PHC2 TGIF1 ZBTB32 SETD5 ATF7IP YLPM1 SMARCA2 RERE SPEN EP300 EPAS1 CUX1 | 1.56e-05 | 1413 | 248 | 36 | GO:1902679 |
| GeneOntologyBiologicalProcess | amacrine cell differentiation | 5.47e-05 | 18 | 248 | 4 | GO:0035881 | |
| GeneOntologyBiologicalProcess | neuron development | TANC2 MAP1A UBE4B MAP2 SCYL1 TSC1 NDN SAMD7 PTCH1 TTC3 PRAG1 ACSL4 MAGI2 HMCN2 SYN1 SECISBP2 ROBO3 NYAP1 PLXNB3 NOTCH3 MRTFA ABI1 ANK3 JADE2 HCN1 MINK1 CRTC1 BARHL2 ZNF335 EIF4G2 TENM1 AUTS2 RERE EP300 CUX1 | 7.50e-05 | 1463 | 248 | 35 | GO:0048666 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 BRPF3 KMT2B CHD4 SMARCAD1 NDN SAMD7 PWWP2A ZBTB7A SFPQ EP400 JADE2 BICRA CHD7 EPOP SETD5 ATF7IP BRD4 ZNF335 SMARCA2 RERE EP300 | 9.53e-05 | 741 | 248 | 22 | GO:0006338 |
| GeneOntologyBiologicalProcess | central nervous system development | NCOA6 SCYL1 PEX13 TSC1 NDN VCX3B PTCH1 CIC HOXB2 PYGO2 ATXN1 SEC16A SECISBP2 NOTCH3 MRTFA VCX2 VCX3A FOXN4 MINK1 CHD7 XRCC1 SHROOM2 ATXN1L VCY AATK MTF1 ZNF335 RERE HYDIN VCX | 1.14e-04 | 1197 | 248 | 30 | GO:0007417 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TANC2 NCOA6 SPEG MATR3 TSC1 PTCH1 HOXA5 ACSL4 HOXB2 SEC24D AMOT MYO18B EPN1 PRRC2B ATF7 ABI1 RBBP6 SOCS3 CHD7 TGIF1 LATS1 BRD4 ZNF335 EP300 EPAS1 | 1.50e-04 | 929 | 248 | 25 | GO:0009792 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 MAP1A MAP2 NDN RREB1 PTCH1 TTC3 HMCN2 ROBO3 NYAP1 PLXNB3 NOTCH3 ABI1 ANK3 JADE2 MINK1 BARHL2 ZNF335 EIF4G2 AUTS2 RERE EP300 CUX1 | 1.50e-04 | 819 | 248 | 23 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 MAP1A MAP2 NDN RREB1 PTCH1 TTC3 HMCN2 ROBO3 NYAP1 PLXNB3 NOTCH3 ABI1 ANK3 JADE2 MINK1 BARHL2 ZNF335 EIF4G2 AUTS2 RERE EP300 CUX1 | 1.70e-04 | 826 | 248 | 23 | GO:0048858 |
| GeneOntologyBiologicalProcess | vesicle localization | TANC2 MAP2 MAGI2 SYNJ1 AP1G1 SEC16A SYN1 PDCD6IP PCLO STAM SHROOM2 | 2.11e-04 | 247 | 248 | 11 | GO:0051648 |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 2.12e-04 | 71 | 248 | 6 | GO:0097479 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | TANC2 NCOA6 SPEG MATR3 TSC1 PTCH1 HOXA5 HOXB2 SEC24D AMOT MYO18B EPN1 PRRC2B ATF7 ABI1 RBBP6 SOCS3 CHD7 TGIF1 LATS1 BRD4 ZNF335 EP300 EPAS1 | 2.57e-04 | 906 | 248 | 24 | GO:0043009 |
| GeneOntologyCellularComponent | chromatin | BRPF3 TGIF2 FOXB2 SREBF1 KLF14 CHD4 SMARCAD1 HSFY1 CIC HOXA5 HOXB2 KLF5 NR1H2 ATF7 SFPQ MAGED1 AKIRIN1 EP400 JADE2 FOXN4 BICRA E2F2 CHD7 XRCC1 MLXIP PHC2 TGIF1 ZBTB32 ZFHX4 NKX2-4 SETD5 BRD4 BARHL2 SMARCA2 ANKRD17 EP300 EPAS1 CUX1 | 7.94e-06 | 1480 | 252 | 38 | GO:0000785 |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 MAP1A MAP2 LRFN3 TSC1 CHD4 MAGI2 PRR12 SYN1 DGCR8 MPP2 ABI1 ANK3 PCLO MINK1 CRTC1 PRRT2 EIF4G2 | 2.13e-05 | 477 | 252 | 18 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 MAP1A MAP2 LRFN3 TSC1 MAGI2 PRR12 SYN1 DGCR8 MPP2 ABI1 ANK3 PCLO MINK1 CRTC1 PRRT2 EIF4G2 | 3.67e-05 | 451 | 252 | 17 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 MAP1A MAP2 LRFN3 TSC1 CHD4 MAGI2 PRR12 SYN1 DGCR8 MPP2 ABI1 ANK3 PCLO MINK1 CRTC1 PRRT2 EIF4G2 | 7.03e-05 | 523 | 252 | 18 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 MAP1A MAP2 LRFN3 TSC1 MAGI2 PRR12 SYN1 DGCR8 MPP2 ABI1 ANK3 PCLO MINK1 CRTC1 PRRT2 EIF4G2 | 1.39e-04 | 503 | 252 | 17 | GO:0099572 |
| GeneOntologyCellularComponent | bicellular tight junction | 1.93e-04 | 131 | 252 | 8 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 2.89e-04 | 139 | 252 | 8 | GO:0070160 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 4.53e-04 | 13 | 252 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | apical junction complex | 6.80e-04 | 158 | 252 | 8 | GO:0043296 | |
| GeneOntologyCellularComponent | primary dendrite | 8.55e-04 | 4 | 252 | 2 | GO:0150001 | |
| GeneOntologyCellularComponent | axon | TANC2 RIN3 MAP1A MAP2 LRFN3 TSC1 PTCH1 HMCN2 SYNJ1 SYN1 ROBO3 MICAL1 ABI1 ANK3 HCN1 PCLO MINK1 BCAR1 PRRT2 EIF4G2 AUTS2 RIMBP2 | 1.21e-03 | 891 | 252 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L NCOA6 KMT2B WDR33 CDK12 CHD4 SAMD7 BCL9 ZBTB7A PYGO2 AMOT AMOTL1 NR1H2 DGCR8 ATF7 SFPQ EP400 BICRA RANBP3 E2F2 XRCC1 MLXIP PHC2 MED15 EPOP SETD5 BRD4 ZNF335 SMARCA2 RERE | 1.23e-03 | 1377 | 252 | 30 | GO:0140513 |
| GeneOntologyCellularComponent | postsynapse | TANC2 CTTNBP2 MAP1A MAP2 LRFN3 TSC1 MAGI2 TMUB1 PRR12 KCND1 SYN1 DGCR8 EPN1 MPP2 ABI1 ANK3 HCN1 PCLO MINK1 CRTC1 PRRT2 RPH3A EIF4G2 SNTA1 | 1.37e-03 | 1018 | 252 | 24 | GO:0098794 |
| HumanPheno | Autistic behavior | TANC2 PNKP KMT2B UBE4B TSC1 NDN RREB1 CIC SCAF4 ACSL4 ZBTB7A SYNJ1 AP1G1 SYN1 ANK3 BICRA HCN1 CHD7 PRRT2 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 CAPN15 SON | 5.53e-07 | 678 | 89 | 30 | HP:0000729 |
| HumanPheno | Abnormal thought pattern | TANC2 UBE4B TSC1 NDN CIC AP1G1 EMC10 DGCR8 NOTCH3 ANK3 BICRA HCN1 CHD7 PRRT2 ECM1 SETD5 BRD4 SMARCA2 AUTS2 RERE SPEN EP300 | 9.55e-07 | 404 | 89 | 22 | HP:5200269 |
| HumanPheno | Diagnostic behavioral phenotype | TANC2 PNKP KMT2B UBE4B TSC1 NDN RREB1 CIC SCAF4 ACSL4 ZBTB7A SYNJ1 AP1G1 SYN1 ESPN ANK3 BICRA HCN1 CHD7 PRRT2 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 CAPN15 SON | 1.38e-06 | 747 | 89 | 31 | HP:0025783 |
| HumanPheno | Perseverative thought | TANC2 UBE4B TSC1 NDN CIC AP1G1 EMC10 NOTCH3 ANK3 BICRA HCN1 CHD7 PRRT2 SETD5 BRD4 SMARCA2 AUTS2 RERE SPEN EP300 | 5.00e-06 | 377 | 89 | 20 | HP:0030223 |
| HumanPheno | Disordered formal thought process | TANC2 UBE4B TSC1 NDN CIC AP1G1 EMC10 NOTCH3 ANK3 BICRA HCN1 CHD7 PRRT2 SETD5 BRD4 SMARCA2 AUTS2 RERE SPEN EP300 | 7.17e-06 | 386 | 89 | 20 | HP:0025769 |
| HumanPheno | Disinhibition | TANC2 PNKP KMT2B UBE4B TSC1 NDN RREB1 PTCH1 CIC SCAF4 SYNJ1 AP1G1 FGD1 SYN1 DGCR8 PDCD6IP ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 7.35e-06 | 807 | 89 | 31 | HP:0000734 |
| HumanPheno | Inappropriate behavior | TANC2 PNKP KMT2B UBE4B TSC1 NDN RREB1 PTCH1 CIC SCAF4 SYNJ1 AP1G1 FGD1 SYN1 DGCR8 PDCD6IP ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 7.35e-06 | 807 | 89 | 31 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | TANC2 PNKP KMT2B UBE4B TSC1 NDN RREB1 PTCH1 CIC SCAF4 SYNJ1 AP1G1 FGD1 SYN1 DGCR8 PDCD6IP ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 7.35e-06 | 807 | 89 | 31 | HP:5200123 |
| HumanPheno | Social disinhibition | TANC2 PNKP KMT2B UBE4B TSC1 NDN RREB1 PTCH1 CIC SCAF4 SYNJ1 AP1G1 FGD1 SYN1 DGCR8 PDCD6IP ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 7.35e-06 | 807 | 89 | 31 | HP:5200029 |
| HumanPheno | Abnormal experience of reality | TANC2 KMT2B MATR3 TSC1 NDN RREB1 PTCH1 CIC ACSL4 SYNJ1 AP1G1 EMC10 DGCR8 NOTCH3 ESPN HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 ZFYVE26 EIF3F EP300 EPAS1 SON | 7.70e-06 | 646 | 89 | 27 | HP:5200423 |
| HumanPheno | Abnormal fear-induced behavior | TANC2 KMT2B MATR3 TSC1 RREB1 PTCH1 CIC ACSL4 SYNJ1 AP1G1 EMC10 DGCR8 NOTCH3 ESPN PDCD6IP HCN1 CHD7 PRRT2 TGIF1 SETD5 BRD4 ZFYVE26 EP300 EPAS1 | 9.71e-06 | 538 | 89 | 24 | HP:0100852 |
| HumanPheno | Impairment in personality functioning | TANC2 PNKP KMT2B UBE4B MATR3 TSC1 NDN RREB1 PTCH1 CIC SCAF4 ACSL4 SYNJ1 AP1G1 FGD1 SYN1 EMC10 DGCR8 NOTCH3 ESPN PDCD6IP ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 ZFYVE26 RERE SPEN EP300 EPAS1 ZMYM3 | 1.32e-05 | 1141 | 89 | 38 | HP:0031466 |
| HumanPheno | Restricted or repetitive behaviors or interests | TANC2 UBE4B TSC1 NDN CIC AP1G1 EMC10 ANK3 BICRA HCN1 CHD7 PRRT2 SETD5 BRD4 SMARCA2 AUTS2 RERE SPEN EP300 | 1.34e-05 | 368 | 89 | 19 | HP:0031432 |
| HumanPheno | Abnormal judgment | TANC2 KMT2B MATR3 TSC1 RREB1 PTCH1 CIC ACSL4 SYNJ1 AP1G1 EMC10 DGCR8 NOTCH3 ESPN HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 EP300 EPAS1 | 1.60e-05 | 516 | 89 | 23 | HP:5200401 |
| HumanPheno | Recurrent maladaptive behavior | TANC2 TET2 PNKP KMT2B UBE4B MATR3 TSC1 NDN RREB1 PTCH1 CIC SCAF4 ACSL4 SYNJ1 AP1G1 FGD1 SYN1 EMC10 DGCR8 NOTCH3 ESPN PDCD6IP ANK3 BICRA HCN1 GRB10 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 ZFYVE26 RERE SPEN EP300 EPAS1 ZMYM3 | 1.63e-05 | 1293 | 89 | 41 | HP:5200241 |
| HumanPheno | Hyperactivity | TANC2 PNKP KMT2B TSC1 RREB1 PTCH1 CIC SYNJ1 AP1G1 FGD1 PDCD6IP ANK3 HCN1 CHD7 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 1.81e-05 | 558 | 89 | 24 | HP:0000752 |
| HumanPheno | Reduced attention regulation | TANC2 PNKP KMT2B TSC1 RREB1 PTCH1 CIC SYNJ1 FGD1 SECISBP2 EMC10 HCN1 CHD7 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 2.19e-05 | 526 | 89 | 23 | HP:5200044 |
| HumanPheno | Abnormally increased volition | TANC2 PNKP KMT2B UBE4B TSC1 NDN RREB1 PTCH1 CIC SCAF4 SYNJ1 AP1G1 FGD1 SYN1 DGCR8 PDCD6IP ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 3.40e-05 | 869 | 89 | 31 | HP:5200263 |
| HumanPheno | Short attention span | TANC2 PNKP KMT2B TSC1 RREB1 PTCH1 CIC SYNJ1 FGD1 SECISBP2 HCN1 CHD7 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 5.28e-05 | 517 | 89 | 22 | HP:0000736 |
| HumanPheno | Maladaptive fear-related cognitions | TANC2 KMT2B MATR3 TSC1 RREB1 PTCH1 CIC ACSL4 SYNJ1 AP1G1 EMC10 NOTCH3 ESPN HCN1 CHD7 PRRT2 TGIF1 SETD5 BRD4 EP300 EPAS1 | 5.96e-05 | 483 | 89 | 21 | HP:5200230 |
| HumanPheno | Anxiety | TANC2 KMT2B MATR3 TSC1 RREB1 PTCH1 CIC ACSL4 SYNJ1 AP1G1 EMC10 NOTCH3 ESPN HCN1 CHD7 PRRT2 TGIF1 SETD5 BRD4 EP300 EPAS1 | 5.96e-05 | 483 | 89 | 21 | HP:0000739 |
| HumanPheno | Attention deficit hyperactivity disorder | TANC2 KMT2B TSC1 RREB1 PTCH1 CIC SYNJ1 FGD1 HCN1 CHD7 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN ZMYM3 | 6.77e-05 | 413 | 89 | 19 | HP:0007018 |
| HumanPheno | Abnormal social development | TANC2 PNKP KMT2B UBE4B TSC1 NDN RREB1 PTCH1 CIC SCAF4 SYNJ1 AP1G1 FGD1 SYN1 DGCR8 PDCD6IP ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 8.14e-05 | 908 | 89 | 31 | HP:0025732 |
| HumanPheno | Abnormal aortic arch morphology | 1.03e-04 | 109 | 89 | 9 | HP:0012303 | |
| HumanPheno | Aggressive behavior | PNKP UBE4B TSC1 NDN PTCH1 SCAF4 SYNJ1 AP1G1 SYN1 DGCR8 ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 BRD4 SMARCA2 RERE SPEN EP300 | 1.55e-04 | 516 | 89 | 21 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | PNKP UBE4B TSC1 NDN PTCH1 SCAF4 SYNJ1 AP1G1 SYN1 DGCR8 ANK3 HCN1 CHD7 PRRT2 ECM1 TGIF1 BRD4 SMARCA2 RERE SPEN EP300 | 1.55e-04 | 516 | 89 | 21 | HP:0006919 |
| HumanPheno | Reduced impulse control | TANC2 TET2 PNKP KMT2B UBE4B TSC1 NDN RREB1 PTCH1 CIC SCAF4 SYNJ1 AP1G1 FGD1 SYN1 DGCR8 PDCD6IP ANK3 HCN1 GRB10 CHD7 PRRT2 ECM1 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 ANKRD17 RERE SPEN EP300 ZMYM3 | 1.61e-04 | 1032 | 89 | 33 | HP:5200045 |
| HumanPheno | Rib fusion | 1.63e-04 | 48 | 89 | 6 | HP:0000902 | |
| HumanPheno | Bulbous nose | KMT2B RREB1 SCAF4 DGCR8 MYO18B BICRA COL18A1 SETD5 SMARCA2 RERE SPEN CUX1 | 1.67e-04 | 201 | 89 | 12 | HP:0000414 |
| HumanPheno | Bifid ribs | 1.74e-04 | 17 | 89 | 4 | HP:0000892 | |
| HumanPheno | Compulsive behaviors | 3.82e-04 | 158 | 89 | 10 | HP:0000722 | |
| HumanPheno | Language impairment | TANC2 ZNF142 KMT2B UBE4B CCDC174 SPEG MATR3 NDN PTCH1 CIC SCAF4 ACSL4 ZBTB7A SYNJ1 AP1G1 EMC10 NOTCH3 ANK3 HCN1 GRB10 PRRT2 TGIF1 SETD5 BRD4 SMARCA2 AUTS2 FMN2 ANKRD17 RERE EIF3F SPEN HYDIN EP300 ZMYM3 CUX1 | 4.11e-04 | 1178 | 89 | 35 | HP:0002463 |
| HumanPheno | Sleep abnormality | TANC2 TET2 PNKP MATR3 TSC1 NDN PTCH1 CIC ZBTB7A SYNJ1 EMC10 NOTCH3 ANK3 BICRA GRB10 TGIF1 SETD5 BRD4 RERE EIF3F EP300 ZMYM3 | 4.30e-04 | 596 | 89 | 22 | HP:0002360 |
| MousePheno | abnormal fetal cardiomyocyte morphology | 6.89e-07 | 35 | 208 | 7 | MP:0008788 | |
| MousePheno | abnormal fetal cardiomyocyte number | 1.45e-05 | 11 | 208 | 4 | MP:0031610 | |
| MousePheno | pericardial effusion | 4.10e-05 | 111 | 208 | 9 | MP:0005312 | |
| MousePheno | abnormal cardiovascular development | NCOA6 KMT2B SPEG MATR3 TSC1 CHD4 PTCH1 FAF2 AMOT KLF5 MYO18B NOTCH3 PRRC2B MRTFA ATMIN RBPMS ABI1 GAS2L3 CHD7 BCAR1 SETD5 SHARPIN ANKRD17 RERE SPEN EP300 EPAS1 | 5.90e-05 | 802 | 208 | 27 | MP:0002925 |
| MousePheno | effusion | NCOA6 KMT2B UBE4B NACA TSC1 MYO18B TGIF1 SETD5 ANKRD17 EP300 | 9.17e-05 | 152 | 208 | 10 | MP:0021205 |
| MousePheno | abnormal epicardium morphology | 9.74e-05 | 17 | 208 | 4 | MP:0003057 | |
| MousePheno | microphthalmia | PNKP PFAS REXO1 PYGO2 FAF2 FGD1 ATMIN PDCD6IP BICRA MINK1 MTF1 BRD4 TMEM209 RERE EP300 CAPN15 | 1.04e-04 | 362 | 208 | 16 | MP:0001297 |
| Domain | VCX_VCY | 1.58e-07 | 5 | 251 | 4 | PF15231 | |
| Domain | VCX/VCY1 | 1.58e-07 | 5 | 251 | 4 | IPR026653 | |
| Domain | SNF2_N | 6.31e-05 | 32 | 251 | 5 | IPR000330 | |
| Domain | SNF2_N | 6.31e-05 | 32 | 251 | 5 | PF00176 | |
| Domain | BAR | 1.05e-04 | 19 | 251 | 4 | PS51021 | |
| Domain | Znf_FYVE_PHD | 1.70e-04 | 147 | 251 | 9 | IPR011011 | |
| Domain | ALIX_LYPXL_bnd | 1.80e-04 | 2 | 251 | 2 | PF13949 | |
| Domain | BCL9 | 1.80e-04 | 2 | 251 | 2 | PF11502 | |
| Domain | Bcl-9 | 1.80e-04 | 2 | 251 | 2 | IPR015668 | |
| Domain | ALIX_V_dom | 1.80e-04 | 2 | 251 | 2 | IPR025304 | |
| Domain | BCL9_beta-catenin-bd_dom | 1.80e-04 | 2 | 251 | 2 | IPR024670 | |
| Domain | Bromodomain_CS | 3.77e-04 | 26 | 251 | 4 | IPR018359 | |
| Domain | BAT2_N | 5.35e-04 | 3 | 251 | 2 | PF07001 | |
| Domain | Angiomotin | 5.35e-04 | 3 | 251 | 2 | IPR009114 | |
| Domain | AXH | 5.35e-04 | 3 | 251 | 2 | SM00536 | |
| Domain | REKLES | 5.35e-04 | 3 | 251 | 2 | PS51486 | |
| Domain | AXH | 5.35e-04 | 3 | 251 | 2 | PF08517 | |
| Domain | Ataxin_AXH_dom | 5.35e-04 | 3 | 251 | 2 | IPR003652 | |
| Domain | REKLES_domain | 5.35e-04 | 3 | 251 | 2 | IPR023334 | |
| Domain | Angiomotin_C | 5.35e-04 | 3 | 251 | 2 | IPR024646 | |
| Domain | AXH | 5.35e-04 | 3 | 251 | 2 | PS51148 | |
| Domain | BAT2_N | 5.35e-04 | 3 | 251 | 2 | IPR009738 | |
| Domain | Angiomotin_C | 5.35e-04 | 3 | 251 | 2 | PF12240 | |
| Domain | PRRC2 | 5.35e-04 | 3 | 251 | 2 | IPR033184 | |
| Domain | SH3 | ARHGAP42 OBSCN PEX13 CASKIN2 ARHGEF37 MPP2 ABI1 STAM BCAR1 RIMBP2 | 7.07e-04 | 216 | 251 | 10 | SM00326 |
| Domain | SH3 | ARHGAP42 OBSCN PEX13 CASKIN2 ARHGEF37 MPP2 ABI1 STAM BCAR1 RIMBP2 | 7.07e-04 | 216 | 251 | 10 | PS50002 |
| Domain | SH3_domain | ARHGAP42 OBSCN PEX13 CASKIN2 ARHGEF37 MPP2 ABI1 STAM BCAR1 RIMBP2 | 8.14e-04 | 220 | 251 | 10 | IPR001452 |
| Domain | BAR | 9.68e-04 | 15 | 251 | 3 | SM00721 | |
| Domain | BAR | 9.68e-04 | 15 | 251 | 3 | PF03114 | |
| Domain | HSA | 1.06e-03 | 4 | 251 | 2 | SM00573 | |
| Domain | HSA | 1.06e-03 | 4 | 251 | 2 | PS51204 | |
| Domain | HSA_dom | 1.06e-03 | 4 | 251 | 2 | IPR014012 | |
| Domain | HSA | 1.06e-03 | 4 | 251 | 2 | PF07529 | |
| Domain | MAGE | 1.08e-03 | 34 | 251 | 4 | SM01373 | |
| Domain | - | BRPF3 KMT2B UBE4B CHD4 TTC3 RNF214 MEX3A PYGO2 FGD1 RBBP6 JADE2 PCLO RPH3A ZFYVE26 SCAF11 | 1.16e-03 | 449 | 251 | 15 | 3.30.40.10 |
| Domain | BAR_dom | 1.18e-03 | 16 | 251 | 3 | IPR004148 | |
| Domain | Rho_GTPase_activation_prot | 1.20e-03 | 88 | 251 | 6 | IPR008936 | |
| Domain | MAGE | 1.34e-03 | 36 | 251 | 4 | PS50838 | |
| Domain | MHD_dom | 1.34e-03 | 36 | 251 | 4 | IPR002190 | |
| Domain | MAGE | 1.34e-03 | 36 | 251 | 4 | PF01454 | |
| Domain | Znf_RING/FYVE/PHD | BRPF3 KMT2B UBE4B CHD4 TTC3 RNF214 MEX3A PYGO2 FGD1 RBBP6 JADE2 PCLO RPH3A ZFYVE26 SCAF11 | 1.44e-03 | 459 | 251 | 15 | IPR013083 |
| Domain | RhoGAP | 1.46e-03 | 62 | 251 | 5 | SM00324 | |
| Domain | BROMODOMAIN_1 | 1.48e-03 | 37 | 251 | 4 | PS00633 | |
| Domain | RhoGAP | 1.57e-03 | 63 | 251 | 5 | PF00620 | |
| Domain | Bromodomain | 1.64e-03 | 38 | 251 | 4 | PF00439 | |
| Domain | RhoGAP_dom | 1.68e-03 | 64 | 251 | 5 | IPR000198 | |
| Domain | RHOGAP | 1.68e-03 | 64 | 251 | 5 | PS50238 | |
| Domain | - | 1.68e-03 | 64 | 251 | 5 | 1.10.555.10 | |
| Domain | BRO1 | 1.75e-03 | 5 | 251 | 2 | PF03097 | |
| Domain | BRO1_dom | 1.75e-03 | 5 | 251 | 2 | IPR004328 | |
| Domain | BRO1 | 1.75e-03 | 5 | 251 | 2 | SM01041 | |
| Domain | BRO1 | 1.75e-03 | 5 | 251 | 2 | PS51180 | |
| Domain | DUF4704 | 1.75e-03 | 5 | 251 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.75e-03 | 5 | 251 | 2 | PF15787 | |
| Domain | - | 1.75e-03 | 5 | 251 | 2 | 1.25.40.280 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 NCOA6 RIN3 KMT2B UBE4B CDK12 SPEG SREBF1 OBSCN PFAS PTCH1 BCL9 MBD6 ANKHD1 TTC3 STK11IP PRAG1 REXO1 CIC PRR12 SCAF1 WIZ SYNJ1 NBEAL2 SEC16A MICAL3 ZNF579 WNK2 PRRC2B IQCE ARAP1 ATMIN FAM193B ARID3A EP400 BICRA AOC2 SOCS3 GRB10 ARHGAP17 MLXIP PHC2 RABL6 UNC119 AATK EPOP ADAMTSL5 SETD5 PLA2G4B BRD4 ZNF335 ZFYVE26 CEP131 MAPKBP1 SPEN EP300 | 1.85e-30 | 1105 | 258 | 56 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 MAP1A SCYL1 SMARCAD1 PTCH1 BCL9 CIC ZNF469 FAF2 KLF5 EPN1 NYAP1 WNK2 MRTFA IQCE ARAP1 MAGED1 AKIRIN1 PDCD6IP ANK3 EP400 RBBP6 BICRA RANBP3 CHD7 BCAR1 AATK LATS1 UBQLN3 YLPM1 SPEN NEURL4 SON | 1.33e-23 | 430 | 258 | 33 | 35044719 |
| Pubmed | TET2 BCL9L NCOA6 KMT2B WDR33 CCDC174 MATR3 NACA RREB1 BCL9 MBD6 ANKHD1 CIC SCAF4 HOXA5 PRR12 RNF214 ZBTB7A WIZ PYGO2 ATXN1 KLF5 WDR20 SEC16A PRRC2A PRRC2B MAGED1 ARID3A EP400 RBBP6 BICRA LARP1 CHD7 XRCC1 ATXN1L MED15 SRRT ZFHX4 NKX2-4 ATF7IP YLPM1 SMARCA2 AUTS2 OTUD4 ANKRD17 SCAF11 CEP131 RERE EIF3F SPEN EP300 ZMYM3 CUX1 | 1.88e-22 | 1429 | 258 | 53 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 KMT2B UBE4B CDK12 MATR3 CHD4 SMARCAD1 RREB1 BCL9 REXO1 CIC SCAF4 SCAF1 ZBTB7A NAF1 SEC16A MICAL3 ZNF579 PRRC2A MRTFA EP400 RBBP6 MINK1 LARP1 CHD7 PHC2 SRRT LATS1 BRD4 ZNF335 YLPM1 EIF4G2 SMARCA2 OTUD4 ANKRD17 SCAF11 RERE SPEN ZMYM3 SON | 4.51e-22 | 774 | 258 | 40 | 15302935 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 BCL9L NCOA6 KMT2B RREB1 BCL9 MBD6 PRR12 WIZ PYGO2 ATXN1 SEC16A PRRC2B ARID3A EP400 BICRA CHD7 ATXN1L MED15 ZFHX4 SMARCA2 AUTS2 RERE SPEN EP300 ZMYM3 | 2.06e-18 | 351 | 258 | 26 | 38297188 |
| Pubmed | TET2 BCL9L NCOA6 WDR33 CHD4 BCL9 CIC PRR12 WIZ PYGO2 ATXN1 KLF5 PRRC2B EP400 RANBP3 CHD7 ATXN1L MED15 BRD4 YLPM1 SMARCA2 RERE CUX1 | 7.96e-18 | 268 | 258 | 23 | 33640491 | |
| Pubmed | BCL9L PNKP KMT2B AUP1 CDK12 NACA ANKHD1 CIC SCAF4 PRR12 PWWP2A SCAF1 ZBTB7A WIZ AP1G1 WDR20 DGCR8 ZNF579 EPN1 PRRC2A ABI1 MAGED1 EP400 RBBP6 MINK1 CRTC1 CHD7 XRCC1 PHC2 MED15 SRRT COL18A1 SETD5 EIF4G2 LRCH4 SMARCA2 PALM3 OTUD4 ANKRD17 SCAF11 CEP131 EIF3F SPEN ZMYM3 SON | 1.14e-15 | 1497 | 258 | 45 | 31527615 | |
| Pubmed | TANC2 CTTNBP2 MATR3 SH3BP1 TSC1 CHD4 BCL9 TTC3 MAGI2 WIZ SYNJ1 SEC16A SYN1 PRRC2A WNK2 PRRC2B VGF MPP2 SFPQ ABI1 MAGED1 PDCD6IP ANK3 PRR36 HCN1 MINK1 CHD7 RPH3A ATF7IP YLPM1 OTUD4 ANKRD17 RIMBP2 CEP131 NEURL4 CUX1 | 1.74e-15 | 963 | 258 | 36 | 28671696 | |
| Pubmed | NCOA6 KMT2B WDR33 CDK12 MATR3 ANKHD1 SCAF4 WIZ SYNJ1 AMOT AMOTL1 SEC16A PRRC2A PRRC2B ANK3 EP400 RBBP6 RANBP3 LARP1 PTPN23 MED15 LATS1 BRD4 YLPM1 SPEN EP300 CUX1 | 1.19e-14 | 549 | 258 | 27 | 38280479 | |
| Pubmed | KMT2B MATR3 SREBF1 SCYL1 MBD6 ANKHD1 CIC SCAF1 ATXN1 SECISBP2 PRRC2A WNK2 PRRC2B FAM193B RBPMS TRIB2 MAGED1 XRCC1 ECM1 ATXN1L TXNDC11 PHC2 MED15 ZBTB32 SCAF11 RERE MAPKBP1 SPEN | 1.91e-14 | 608 | 258 | 28 | 16713569 | |
| Pubmed | TET2 WDR33 ZNF185 BCL9 CIC PRR12 AMOT AMOTL1 PRRC2B SFPQ MAGED1 BICRA ATXN1L MED15 AUTS2 EP300 | 3.68e-14 | 152 | 258 | 16 | 38360978 | |
| Pubmed | NCOA6 CDK12 BCL9 CIC PRR12 WIZ ARID3A EP400 CHD7 SMARCA2 SPEN EP300 CUX1 | 5.07e-14 | 83 | 258 | 13 | 28794006 | |
| Pubmed | UBE4B SPEG TSC1 SMARCAD1 MAGI2 FAF2 ZFR2 SEC16A MICAL3 PLXNB3 PRRC2B ATMIN EP400 GRB10 MLXIP SETD5 OTUD4 RIMBP2 RERE MAPKBP1 SPEN ZMYM3 SON | 6.71e-14 | 407 | 258 | 23 | 12693553 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 RREB1 PRR12 HOXB2 WIZ SYNJ1 SEC16A PDCD6IP EP400 BICRA PCLO LARP1 CHD7 XRCC1 MED15 ZFHX4 ATF7IP BRD4 SMARCA2 AUTS2 EP300 CUX1 | 3.74e-13 | 398 | 258 | 22 | 35016035 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 TET2 NCOA6 MAP2 MATR3 PRAG1 DENND2B CIC SYNJ1 ATXN1 CASKIN2 AMOT SEC16A ABI1 PDCD6IP RANBP3 MINK1 LARP1 GRB10 ARHGAP17 CRTC1 BCAR1 MLXIP NUAK2 UNC119 SRRT LATS1 BRD4 FMN2 ANKRD17 CEP131 | 4.94e-13 | 861 | 258 | 31 | 36931259 |
| Pubmed | TET2 KMT2B CHD4 RREB1 ANKHD1 CIC PRR12 WIZ SYNJ1 AMOT SEC16A MRTFA CRTC1 CHD7 ZFHX4 ATF7IP BRD4 ANKRD17 CEP131 RERE ZMYM3 CUX1 | 9.92e-13 | 418 | 258 | 22 | 34709266 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 PNKP KMT2B AUP1 WDR33 MATR3 SREBF1 CHD4 RREB1 CIC SCAF4 PRR12 PWWP2A SCAF1 ZBTB7A WIZ KLF5 ATF7 SFPQ EP400 RBBP6 CHD7 XRCC1 MLXIP PHC2 SRRT EPOP BRD4 YLPM1 EIF4G2 TMEM209 SCAF11 SPEN EP300 ZMYM3 CUX1 SON | 2.33e-12 | 1294 | 258 | 37 | 30804502 |
| Pubmed | ZNF142 MAP1A FMNL2 CIC TSC22D1 ATXN1 WIPF2 WNK2 SFPQ PDCD6IP ANK3 RBBP6 JADE2 BICRA ARHGAP17 PTPN23 CRTC1 LATS1 ATF7IP ANKRD17 EP300 EPAS1 CUX1 | 2.63e-12 | 486 | 258 | 23 | 20936779 | |
| Pubmed | NCOA6 PNKP KMT2B AUP1 CDK12 TTC3 FMNL2 DENND2B SEC24D AP1G1 SECISBP2 EPN1 SFPQ PDCD6IP ANK3 RBBP6 STAM ARHGAP5 ATF7IP BRD4 YLPM1 EIF4G2 EIF3F EPAS1 SON | 3.29e-12 | 591 | 258 | 25 | 15231748 | |
| Pubmed | TANC2 BRPF3 MAP1A CHD4 SMARCAD1 RREB1 ANKHD1 FMNL2 SCAF1 ZBTB7A ZNF469 WIZ HMCN2 ATXN1 NAF1 WDR20 SEC16A ZNF579 PRRC2B EP400 P3H3 RBBP6 BICRA E2F2 ZFHX4 SETD5 BRD4 SMARCA2 FMN2 ANKRD17 RERE EP300 ZMYM3 SON | 3.56e-12 | 1116 | 258 | 34 | 31753913 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOA6 AUP1 WDR33 CDK12 MATR3 BCL9 ANKHD1 CIC PRR12 PYGO2 SEC16A AGFG2 PRRC2B SFPQ MED15 YLPM1 TMEM209 SMARCA2 AUTS2 ANKRD17 EP300 | 5.74e-12 | 457 | 258 | 22 | 32344865 |
| Pubmed | TANC2 CTTNBP2 MAP1A MAP2 MATR3 ZNF185 TSC1 FMNL2 MAGI2 SYNJ1 AP1G1 AMOT SEC16A SYN1 MICAL3 PRRC2A WNK2 PRRC2B MPP2 MICAL1 SFPQ ABI1 PDCD6IP ANK3 PRR36 PCLO MINK1 LARP1 SHROOM2 RPH3A NUAK2 SRRT ARHGAP5 EIF4G2 OTUD4 RIMBP2 SNTA1 | 4.22e-11 | 1431 | 258 | 37 | 37142655 | |
| Pubmed | TET2 NCOA6 KMT2B CCDC174 CHD4 RREB1 BCL9 CIC SCAF4 PRR12 WIZ KLF5 PRRC2A PRRC2B ATF7 SFPQ ARID3A EP400 BICRA LARP1 CHD7 XRCC1 ATXN1L MED15 TGIF1 BRD4 EIF4G2 SMARCA2 SPEN EP300 ZMYM3 CUX1 | 5.66e-11 | 1103 | 258 | 32 | 34189442 | |
| Pubmed | TET2 NCOA6 BRPF3 CDK12 MATR3 NACA ANKHD1 CASKIN2 AMOT NBEAL2 WNK2 IQCE ARAP1 PDCD6IP EP400 JADE2 LARP1 CRTC1 NUAK2 AUTS2 ANKRD17 SCAF11 | 9.61e-11 | 529 | 258 | 22 | 14621295 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1A CDK12 MATR3 NACA PFAS TSC1 CHD4 ANKHD1 CIC SCAF4 WIZ SYNJ1 NAF1 SEC16A PRRC2A PRRC2B FAM193B SFPQ EP400 RBBP6 RANBP3 LARP1 PTPN23 STAM ATF7IP YLPM1 EIF4G2 ANKRD17 SON | 1.01e-10 | 934 | 258 | 29 | 33916271 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBE4B MAP2 OBSCN TTC3 DENND2B ZBTB7A TSC22D1 SLC35A4 ATXN1 TOX3 MICAL3 ARHGEF37 WNK2 NOTCH3 ARAP1 ESPN ATMIN ATF7 AKIRIN1 PDCD6IP ANK3 JADE2 BICRA MINK1 LARP1 GRB10 BCAR1 SHROOM2 COL18A1 SETD5 SMARCA2 AUTS2 ANKRD17 SCAF11 RERE EP300 CUX1 | 1.29e-10 | 1489 | 258 | 37 | 28611215 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 WDR33 CDK12 CCDC174 MATR3 CHD4 RREB1 CIC SCAF4 WIZ SEC16A DGCR8 PRRC2A SFPQ EP400 RBBP6 BICRA LARP1 CHD7 XRCC1 SRRT ATF7IP BRD4 YLPM1 EIF4G2 SCAF11 SPEN CUX1 SON | 1.65e-10 | 954 | 258 | 29 | 36373674 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | TGIF2 MATR3 CHD4 RREB1 CIC HOXA5 ZBTB7A WIZ ATXN1 ATF7 SFPQ EP400 LARP1 CHD7 ATXN1L SRRT ZFHX4 NKX2-4 OTUD4 EIF3F CUX1 SON | 5.96e-10 | 583 | 258 | 22 | 29844126 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MAP1A WDR33 CCDC174 PFAS TSC1 SMARCAD1 CIC SYNJ1 SEC16A SECISBP2 PRRC2B MAGED1 EP400 RBBP6 ARHGAP17 E2F2 CHD7 BCAR1 ATF7IP CEP131 SPEN ZMYM3 | 6.99e-10 | 588 | 258 | 22 | 38580884 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | MATR3 TSC1 CHD4 HOXA5 WIZ AMOT SFPQ ARID3A EP400 CHD7 PHC2 SRRT BRD4 YLPM1 SMARCA2 EP300 ZMYM3 SON | 2.30e-09 | 411 | 258 | 18 | 35182466 |
| Pubmed | 2.96e-09 | 4 | 258 | 4 | 10903929 | ||
| Pubmed | BCL9L NCOA6 CDK12 NACA BCL9 CIC PRR12 WIZ AMOT DGCR8 RBBP6 BICRA PCLO ARHGAP17 MED15 SRRT ATF7IP EP300 | 3.87e-09 | 425 | 258 | 18 | 24999758 | |
| Pubmed | BRPF3 RIN3 KMT2B PEX13 MYO18B WNK2 NOTCH3 BICRA GRB10 PCDHA5 XRCC1 BCAR1 SHROOM2 BRD4 LTBP2 SPEN | 4.17e-09 | 329 | 258 | 16 | 17474147 | |
| Pubmed | TANC2 MAP1A MAP2 MAGI2 SYNJ1 SYN1 MICAL3 PRRC2A MPP2 ABI1 HCN1 PCLO MINK1 FMN2 RIMBP2 SNTA1 | 8.85e-09 | 347 | 258 | 16 | 17114649 | |
| Pubmed | 1.47e-08 | 5 | 258 | 4 | 10607842 | ||
| Pubmed | AUP1 SCYL1 CHD4 FMNL2 SEC24D WIZ FAF2 AMOT AMOTL1 WDR20 SEC16A DGCR8 PRRC2B IQCE PDCD6IP ANK3 EP400 MINK1 RABL6 ATF7IP CEP131 SPEN CUX1 | 2.32e-08 | 777 | 258 | 23 | 35844135 | |
| Pubmed | NCOA6 KMT2B CHD4 MBD6 EP400 CHD7 PHC2 EPOP SMARCA2 AUTS2 EP300 | 2.91e-08 | 157 | 258 | 11 | 30186101 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | NCOA6 CDK12 MATR3 WIZ SFPQ EP400 RBBP6 RANBP3 CHD7 XRCC1 BRD4 YLPM1 SCAF11 SPEN | 3.20e-08 | 283 | 258 | 14 | 30585729 |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | NCOA6 RREB1 TTC3 SCAF1 RNF214 HMCN2 MICAL3 MPP2 ATMIN MED15 SRRT SPEN EP300 EPAS1 | 3.20e-08 | 283 | 258 | 14 | 18854154 |
| Pubmed | TET2 UBE4B CHD4 SMARCAD1 TTC3 FMNL2 MAGI2 WIZ SYNJ1 NR1H2 DGCR8 PRRC2A PLXNB3 MAGED1 ANK3 JADE2 HCN1 STAM SHROOM2 RPH3A TXNDC11 ARHGAP5 YLPM1 EIF4G2 SHARPIN FMN2 EIF3F SNTA1 EP300 CUX1 | 3.41e-08 | 1285 | 258 | 30 | 35914814 | |
| Pubmed | WDR33 CDK12 CCDC174 NACA PEX13 TSC1 RREB1 MEX3A PROSER3 AMOTL1 SEC16A SECISBP2 MAGED1 EP400 LARP1 ARHGAP17 CHD7 XRCC1 YLPM1 TMEM209 LRCH4 CEP131 | 3.73e-08 | 733 | 258 | 22 | 34672954 | |
| Pubmed | MATR3 OBSCN PTCH1 ANKHD1 TTC3 SYNJ1 AP1G1 AMOT SEC16A MRTFA SFPQ PDCD6IP ANK3 GAS2L3 PTPN23 CRTC1 CHD7 SHROOM2 ATXN1L ARHGAP5 TGIF1 COL18A1 SETD5 EIF4G2 OTUD4 FMN2 ANKRD17 | 4.76e-08 | 1084 | 258 | 27 | 11544199 | |
| Pubmed | KMT2B CDK12 CHD4 CIC SCAF4 WIZ SYNJ1 WIPF2 MRTFA SFPQ ABI1 ARID3A EP400 RBBP6 BRD4 YLPM1 FMN2 SON | 5.57e-08 | 506 | 258 | 18 | 30890647 | |
| Pubmed | 8.09e-08 | 103 | 258 | 9 | 32744500 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | TGIF2 PTCH1 MAGI2 SCAF1 MEX3A SYNJ1 NOTCH3 SFPQ RBBP6 LARP1 CHD7 SRRT YLPM1 EP300 SON | 9.10e-08 | 358 | 258 | 15 | 32460013 |
| Pubmed | CDK12 NACA SREBF1 PFAS SMARCAD1 ANKHD1 PRR12 AP1G1 CASKIN2 MICAL3 EPN1 PRRC2B MAGED1 MINK1 LARP1 CC2D1B ACE2 SRRT LRCH4 ANKRD17 | 1.07e-07 | 650 | 258 | 20 | 38777146 | |
| Pubmed | NCOA6 MAP1A WDR33 CDK12 CCDC174 NACA CIC SCAF4 AP1G1 SEC16A MRTFA PDCD6IP EP400 PTPN23 SMARCA2 CEP131 CUX1 | 1.10e-07 | 472 | 258 | 17 | 38943005 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | BCL9L WDR33 MATR3 BCL9 PRR12 SEC16A NOTCH3 SFPQ MED15 YLPM1 TMEM209 | 1.18e-07 | 180 | 258 | 11 | 35198878 |
| Pubmed | CTTNBP2 OBSCN PEX13 BCL9 TTC3 ACSL4 PWWP2A RNF214 TSC22D1 PYGO2 EMC10 MICAL3 ZNF579 ROBO3 WIPF2 PRRC2B FAM193B RBPMS TRIB2 AOC2 CC2D1B BCAR1 TXNDC11 TGIF1 COL18A1 TENM1 SHARPIN EP300 | 1.32e-07 | 1215 | 258 | 28 | 15146197 | |
| Pubmed | WDR33 CDK12 MATR3 NACA CHD4 ANKHD1 FMNL2 SCAF4 ACSL4 SCAF1 NAF1 SEC16A WIPF2 PRRC2A PRRC2B RBPMS EP400 GAS2L3 LARP1 CHD7 PHC2 SRRT ARHGAP5 COL18A1 YLPM1 OTUD4 ANKRD17 SCAF11 CEP131 SON | 1.39e-07 | 1371 | 258 | 30 | 36244648 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | PNKP MATR3 CHD4 ZBTB7A WIZ KLF5 PRRC2A ATF7 LARP1 XRCC1 ZFHX4 OTUD4 ANKRD17 CUX1 | 1.51e-07 | 321 | 258 | 14 | 32098917 |
| Pubmed | BCL9L CHD4 TTC3 MEX3A AMOTL1 WDR20 SEC16A PRRC2A PRRC2B LARP1 BCAR1 SETD5 EP300 SON | 2.28e-07 | 332 | 258 | 14 | 37433992 | |
| Pubmed | TANC2 NCOA6 ZNF142 AUP1 BCL9 CIC ACSL4 FAF2 PRRC2B PDCD6IP GAS2L3 CHD7 MED15 SMARCA2 OTUD4 ANKRD17 SPEN EP300 CUX1 | 3.68e-07 | 638 | 258 | 19 | 31182584 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SREBF1 HSFY1 RREB1 CIC HOXA5 HOXB2 ZBTB7A TSC22D1 KLF5 TOX3 NR1H2 ATF7 FOXN4 E2F2 MLXIP TGIF1 ZFHX4 NKX2-4 MTF1 BARHL2 ZNF335 RERE EPAS1 | 3.70e-07 | 908 | 258 | 23 | 19274049 |
| Pubmed | 4.04e-07 | 3 | 258 | 3 | 18076704 | ||
| Pubmed | 4.04e-07 | 3 | 258 | 3 | 20637214 | ||
| Pubmed | 4.04e-07 | 3 | 258 | 3 | 20628574 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | AUP1 MATR3 TTC3 RNF214 NAF1 DGCR8 PRRC2A WNK2 PRRC2B SFPQ PCLO LARP1 YLPM1 EIF4G2 OTUD4 ANKRD17 | 4.43e-07 | 462 | 258 | 16 | 31138677 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | WDR33 MATR3 STK11IP SCAF4 AP1G1 AMOT AMOTL1 SEC16A PRRC2A VPS37C SFPQ MAGED1 PDCD6IP RBBP6 LARP1 BCAR1 SRRT COL18A1 ATF7IP YLPM1 TMEM209 AUTS2 CEP131 | 4.82e-07 | 922 | 258 | 23 | 27609421 |
| Pubmed | AUP1 CDK12 MATR3 NACA SCYL1 SCAF4 ZNF469 FAF2 AP1G1 AMOT SESN2 SFPQ RBBP6 LARP1 RABL6 SRRT YLPM1 EIF3F EP300 | 5.21e-07 | 653 | 258 | 19 | 33742100 | |
| Pubmed | MATR3 NACA SCYL1 ANKHD1 SCAF4 SEC16A MICAL3 ZNF579 WIPF2 PRRC2A RANBP3 LARP1 ARHGAP17 XRCC1 | 6.02e-07 | 360 | 258 | 14 | 33111431 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L CDK12 MATR3 SCAF1 HMCN2 MYO18B PRRC2A PRRC2B ANK3 RBBP6 CRTC1 ZFHX4 SPEN SON | 6.22e-07 | 361 | 258 | 14 | 26167880 |
| Pubmed | MATR3 CASKIN2 AMOT SEC16A SECISBP2 PRRC2B MAGED1 ANK3 STAM RABL6 TMEM209 TENM1 | 7.37e-07 | 263 | 258 | 12 | 34702444 | |
| Pubmed | BRPF3 TGIF2 UBE4B AUP1 MATR3 SREBF1 PFAS TSC1 SCAF1 RNF214 MEX3A GID4 WDR20 SEC16A SESN2 ATMIN PDCD6IP BICRA RANBP3 TGIF1 EPOP MTF1 BRD4 YLPM1 ANKRD17 RERE EP300 CAPN15 | 7.67e-07 | 1327 | 258 | 28 | 32694731 | |
| Pubmed | TGIF2 SREBF1 CIC ZBTB7A TSC22D1 WIZ ATXN1 KLF5 TOX3 NR1H2 MRTFA ATF7 ARID3A E2F2 TGIF1 NKX2-4 MTF1 BRD4 SMARCA2 EPAS1 CUX1 | 8.08e-07 | 808 | 258 | 21 | 20412781 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | ANKHD1 RNF214 AMOT AMOTL1 SEC16A SECISBP2 EPN1 MAGED1 STAM MED15 EIF4G2 AUTS2 OTUD4 | 1.01e-06 | 322 | 258 | 13 | 39098523 |
| Pubmed | TANC2 CTTNBP2 PFAS FMNL2 REXO1 SCAF4 PRR12 PWWP2A TSC22D1 MICAL3 KLHL14 FAM193B PTPN23 CC2D1B MON1B NEURL4 | 1.04e-06 | 493 | 258 | 16 | 15368895 | |
| Pubmed | NCOA6 CDK12 SYNJ1 AMOT SEC16A MRTFA ARAP1 PTPN23 CHD7 AATK AUTS2 | 1.09e-06 | 225 | 258 | 11 | 12168954 | |
| Pubmed | 1.25e-06 | 183 | 258 | 10 | 36129980 | ||
| Pubmed | CDK12 PYGO2 SEC16A ZNF579 PRRC2A MRTFA RBBP6 LARP1 GRB10 STAM BCAR1 SRRT OTUD4 CEP131 SPEN SON | 1.35e-06 | 503 | 258 | 16 | 16964243 | |
| Pubmed | ZBTB7A SEC16A MAGEC1 ARID3A EP400 LARP1 CHD7 PHC2 ZFHX4 SMARCA2 SPEN CUX1 | 1.53e-06 | 282 | 258 | 12 | 23667531 | |
| Pubmed | Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. | 1.61e-06 | 4 | 258 | 3 | 24440334 | |
| Pubmed | 1.61e-06 | 4 | 258 | 3 | 31501273 | ||
| Pubmed | TGIF2 ZNF185 SREBF1 CHD4 CIC KLF5 NR1H2 ARID3A JADE2 FOXN4 E2F2 TGIF1 MTF1 BRD4 SMARCA2 EIF3F EPAS1 ZMYM3 CUX1 | 1.76e-06 | 709 | 258 | 19 | 22988430 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 UBE4B WDR33 SCYL1 SMARCAD1 WIZ EP400 RBBP6 RANBP3 XRCC1 SRRT YLPM1 SPEN | 1.90e-06 | 341 | 258 | 13 | 32971831 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.46e-06 | 154 | 258 | 9 | 16055720 | |
| Pubmed | MAP1A MATR3 PFAS CHD4 ANKHD1 ACSL4 TMUB1 MAGED4 AMOT SFPQ MAGED1 PDCD6IP SRRT EIF4G2 TMEM209 ANKRD17 | 2.90e-06 | 534 | 258 | 16 | 35032548 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBE4B AUP1 MATR3 NACA ZNF185 PFAS TSC1 CHD4 SMARCAD1 ANKHD1 ACSL4 FAF2 AP1G1 SEC16A SFPQ PDCD6IP EP400 PTPN23 CHD7 ECM1 SRRT EIF4G2 SMARCA2 ANKRD17 EIF3F ZMYM3 SON | 3.46e-06 | 1353 | 258 | 27 | 29467282 |
| Pubmed | Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis. | 3.99e-06 | 5 | 258 | 3 | 32878998 | |
| Pubmed | CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors. | 3.99e-06 | 5 | 258 | 3 | 32699137 | |
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 3.99e-06 | 5 | 258 | 3 | 24360964 | |
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 3.99e-06 | 5 | 258 | 3 | 32808927 | |
| Pubmed | Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. | 3.99e-06 | 5 | 258 | 3 | 30760710 | |
| Pubmed | 3.99e-06 | 5 | 258 | 3 | 29526553 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | RIN3 KMT2B MATR3 TTC3 PRAG1 CIC DNALI1 TSC22D1 WIZ NR1H2 ZNF579 NOTCH3 ARAP1 MPP2 MICAL1 FAM193B PDCD6IP SOCS3 LARP1 GRB10 PHC2 UNC119 TGIF1 BRD4 | 4.04e-06 | 1124 | 258 | 24 | 21900206 |
| Pubmed | 4.16e-06 | 57 | 258 | 6 | 38223760 | ||
| Pubmed | PFAS TSC1 CIC ACSL4 WIZ CASKIN2 WDR20 SEC16A MICAL3 PRRC2A PRRC2B ANK3 MINK1 PTPN23 STAM XRCC1 BCAR1 ARHGAP5 YLPM1 OTUD4 FMN2 CEP131 NEURL4 | 4.21e-06 | 1049 | 258 | 23 | 27880917 | |
| Pubmed | BCL9L NACA SREBF1 SCYL1 PFAS CHD4 COL22A1 SORCS1 WIZ AP1G1 SEC16A MRTFA SFPQ RBPMS PDCD6IP EP400 PTPN23 ECM1 EP300 | 4.27e-06 | 754 | 258 | 19 | 35906200 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | NBEAL1 CDK12 FMNL2 CIC HOXA5 PRR12 MICAL3 FAM193B CHD7 MLXIP ATXN1L PLA2G4B ZNF335 TMEM209 TENM1 PALM3 | 4.41e-06 | 552 | 258 | 16 | 10737800 |
| Pubmed | NBEAL1 PFAS COL22A1 CIC ZBTB7A SYNJ1 CASKIN2 NAF1 AMOTL1 ZNF579 PRRC2B MPP2 GAS2L3 XRCC1 ECM1 ZNF335 EIF4G2 CEP131 | 4.70e-06 | 689 | 258 | 18 | 36543142 | |
| Pubmed | 5.02e-06 | 16 | 258 | 4 | 29472293 | ||
| Pubmed | TANC2 BCL9L MAP1A MAP2 NACA MAGI2 SYNJ1 EMC10 WNK2 MPP2 VPS37C SFPQ ABI1 MAGED1 PDCD6IP ANK3 HCN1 PCLO MINK1 SHROOM2 RPH3A EIF4G2 TENM1 CEP131 | 5.05e-06 | 1139 | 258 | 24 | 36417873 | |
| Pubmed | 6.46e-06 | 220 | 258 | 10 | 24550385 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.46e-06 | 220 | 258 | 10 | 35785414 | |
| Pubmed | KMT2B MAP2 TSC1 NDN COL22A1 SAMD7 SECISBP2 ROBO3 PRRC2B MPP2 RBPMS ABI1 FOXN4 GRB10 BCAR1 PHC2 UNC119 ZFHX4 EPOP PLA2G4B BRD4 ZFYVE26 | 7.14e-06 | 1006 | 258 | 22 | 15226823 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | PNKP CHD4 SMARCAD1 ANKHD1 CIC ACSL4 WIZ NOTCH3 ATF7 ABI1 ARID3A EP400 LARP1 XRCC1 ZFHX4 ANKRD17 SPEN EP300 ZMYM3 CUX1 | 7.40e-06 | 857 | 258 | 20 | 25609649 |
| Pubmed | 7.94e-06 | 6 | 258 | 3 | 17342728 | ||
| Pubmed | 7.94e-06 | 6 | 258 | 3 | 17113272 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 7.94e-06 | 6 | 258 | 3 | 25184676 | |
| Pubmed | 7.94e-06 | 6 | 258 | 3 | 25633977 | ||
| Interaction | TOP3B interactions | TANC2 NCOA6 RIN3 KMT2B UBE4B CDK12 SPEG SREBF1 OBSCN PFAS PTCH1 BCL9 MBD6 ANKHD1 TTC3 STK11IP PRAG1 REXO1 CIC PRR12 SCAF1 WIZ SYNJ1 NBEAL2 SEC16A SECISBP2 MICAL3 ZNF579 KLHL14 PRRC2A WNK2 PRRC2B IQCE ARAP1 ATMIN FAM193B ARID3A PDCD6IP EP400 BICRA AOC2 SOCS3 PLEKHA4 GRB10 ARHGAP17 MLXIP PHC2 RABL6 UNC119 AATK EPOP ADAMTSL5 SETD5 PLA2G4B BRD4 ZNF335 OTUD4 ANKRD17 ZFYVE26 CEP131 MAPKBP1 SPEN EP300 | 1.16e-18 | 1470 | 250 | 63 | int:TOP3B |
| Interaction | SP7 interactions | TET2 BCL9L NCOA6 KMT2B WDR33 BCL9 CIC SCAF4 PRR12 WIZ PYGO2 ATXN1 PRRC2B ARID3A EP400 RBBP6 BICRA CHD7 ATXN1L SRRT ZFHX4 NKX2-4 YLPM1 SMARCA2 RERE EP300 CUX1 | 1.22e-15 | 304 | 250 | 27 | int:SP7 |
| Interaction | EGR2 interactions | TET2 BCL9L NCOA6 RREB1 BCL9 PRR12 WIZ PYGO2 ATXN1 SEC16A PRRC2B ARID3A EP400 BICRA CHD7 ATXN1L ZFHX4 SMARCA2 RERE EP300 | 3.89e-14 | 171 | 250 | 20 | int:EGR2 |
| Interaction | CRX interactions | TET2 BCL9L RREB1 BCL9 PRR12 WIZ PYGO2 ATXN1 PRRC2B VPS37C RBPMS ARID3A EP400 BICRA CHD7 ATXN1L MED15 ZFHX4 SMARCA2 RERE SPEN EP300 ZMYM3 | 1.16e-13 | 254 | 250 | 23 | int:CRX |
| Interaction | ERG interactions | TET2 NCOA6 MATR3 BCL9 CIC PRR12 PYGO2 ATXN1 SYN1 PRRC2B SFPQ ARID3A BICRA CHD7 ATXN1L ZFHX4 ATF7IP BRD4 SMARCA2 RERE EP300 | 6.59e-13 | 223 | 250 | 21 | int:ERG |
| Interaction | TLE3 interactions | TET2 BCL9L CDK12 BCL9 CIC SCAF4 PRR12 PYGO2 ATXN1 KLF5 AGFG2 MAGED1 ANK3 RBBP6 STAM ATXN1L MED15 SRRT BRD4 AUTS2 OTUD4 RERE SPEN EP300 CUX1 SON | 1.49e-12 | 376 | 250 | 26 | int:TLE3 |
| Interaction | FEV interactions | NCOA6 KMT2B RREB1 BCL9 CIC PRR12 ZBTB7A WIZ ATXN1 PRRC2B ARID3A EP400 BICRA CHD7 ATXN1L ZFHX4 EP300 ZMYM3 CUX1 | 9.55e-12 | 203 | 250 | 19 | int:FEV |
| Interaction | TBR1 interactions | TET2 BCL9L BCL9 CIC PRR12 PYGO2 ATXN1 CHD7 ATXN1L LATS1 ZFHX4 NKX2-4 BRD4 SMARCA2 EP300 | 1.02e-11 | 113 | 250 | 15 | int:TBR1 |
| Interaction | HNF1B interactions | TET2 BCL9 MBD6 CIC PRR12 WIZ ATXN1 PRRC2B ARID3A EP400 BICRA CHD7 ATXN1L ZFHX4 ATF7IP SMARCA2 EP300 CUX1 | 2.79e-11 | 190 | 250 | 18 | int:HNF1B |
| Interaction | AR interactions | TET2 BCL9L NCOA6 WDR33 MATR3 SREBF1 CHD4 RREB1 BCL9 CIC PRR12 ZBTB7A WIZ PYGO2 FAF2 ATXN1 KLF5 WDR20 SEC16A PRRC2B SFPQ MAGED1 EP400 RANBP3 SOCS3 LARP1 CHD7 ATXN1L MED15 SRRT TGIF1 ZBTB32 BRD4 YLPM1 SMARCA2 CEP131 RERE EP300 CUX1 SON | 4.10e-11 | 992 | 250 | 40 | int:AR |
| Interaction | KLF5 interactions | TET2 NCOA6 SREBF1 BCL9 CIC PRR12 ATXN1 KLF5 SEC16A PRRC2A PRRC2B ARID3A EP400 LARP1 ATXN1L BRD4 SMARCA2 EP300 | 4.30e-11 | 195 | 250 | 18 | int:KLF5 |
| Interaction | NUP35 interactions | BCL9L NCOA6 AUP1 WDR33 CDK12 MATR3 BCL9 ANKHD1 CIC PRR12 PYGO2 SEC16A AGFG2 PRRC2B SFPQ PDCD6IP PLEKHA4 BCAR1 MED15 YLPM1 TMEM209 SMARCA2 AUTS2 ANKRD17 EP300 | 1.27e-10 | 424 | 250 | 25 | int:NUP35 |
| Interaction | TBXT interactions | NCOA6 BCL9 CIC PRR12 WIZ ATXN1 ARID3A CHD7 ATXN1L ZFHX4 SMARCA2 SPEN EP300 CUX1 | 1.87e-10 | 116 | 250 | 14 | int:TBXT |
| Interaction | SOX9 interactions | NCOA6 BCL9 CIC PRR12 ZBTB7A ARID3A EP400 CHD7 BRD4 SMARCA2 SPEN EP300 CUX1 | 2.23e-10 | 97 | 250 | 13 | int:SOX9 |
| Interaction | TLX3 interactions | TET2 BCL9L NCOA6 BCL9 CIC PRR12 WIZ PYGO2 ITIH6 MAGED1 ARID3A CHD7 ATXN1L ZBTB32 ZFHX4 SMARCA2 RERE SNTA1 EP300 CUX1 | 7.04e-10 | 291 | 250 | 20 | int:TLX3 |
| Interaction | PAX6 interactions | NCOA6 RREB1 BCL9 TTC3 CIC PRR12 WIZ SYNJ1 ATXN1 PRRC2B VCX2 ARID3A EP400 BICRA RANBP3 CHD7 ATXN1L ZFHX4 SMARCA2 EP300 ZMYM3 CUX1 | 1.21e-09 | 366 | 250 | 22 | int:PAX6 |
| Interaction | PAX8 interactions | TET2 BCL9 CIC PRR12 PYGO2 ATXN1 PRRC2B CHD7 ATXN1L ZFHX4 NKX2-4 SMARCA2 EP300 | 1.23e-09 | 111 | 250 | 13 | int:PAX8 |
| Interaction | EYA4 interactions | TET2 WDR33 ZNF185 BCL9 CIC PRR12 AMOT AMOTL1 PRRC2B SFPQ MAGED1 BICRA MAPK1IP1L ATXN1L MED15 AATK AUTS2 EP300 | 1.57e-09 | 243 | 250 | 18 | int:EYA4 |
| Interaction | YWHAH interactions | TANC2 TET2 NCOA6 RIN3 MAP2 SPEG MATR3 TSC1 PRAG1 DENND2B CIC SYNJ1 ATXN1 CASKIN2 AMOT WDR20 SEC16A WNK2 ABI1 PDCD6IP RANBP3 MINK1 PLEKHA4 LARP1 GRB10 ARHGAP17 CRTC1 BCAR1 MLXIP ATXN1L RPH3A NUAK2 UNC119 SRRT LATS1 BRD4 FMN2 ANKRD17 CEP131 | 3.14e-09 | 1102 | 250 | 39 | int:YWHAH |
| Interaction | GATA2 interactions | NCOA6 BCL9 CIC PRR12 WIZ ATXN1 PRRC2B RBPMS ARID3A CHD7 ATXN1L ZBTB32 ZFHX4 SMARCA2 EP300 CUX1 | 4.03e-09 | 199 | 250 | 16 | int:GATA2 |
| Interaction | KDM1A interactions | TET2 PNKP KMT2B TSC1 CHD4 SMARCAD1 RREB1 ANKHD1 CIC PRR12 WIZ SYNJ1 ATXN1 AMOT SEC16A NR1H2 MRTFA EP400 PLEKHA4 CRTC1 CHD7 PHC2 UNC119 ACE2 ZFHX4 ATF7IP BRD4 SMARCA2 ANKRD17 CEP131 RERE EP300 EPAS1 ZMYM3 CUX1 | 6.38e-09 | 941 | 250 | 35 | int:KDM1A |
| Interaction | PAX9 interactions | BCL9L NCOA6 BCL9 CIC PRR12 PYGO2 ATXN1 VPS37C CHD7 ATXN1L ZFHX4 SMARCA2 EP300 | 8.72e-09 | 130 | 250 | 13 | int:PAX9 |
| Interaction | HNF4A interactions | NCOA6 KMT2B SREBF1 RREB1 CIC PRR12 WIZ ATXN1 ARID3A EP400 BICRA CHD7 ATF7IP SMARCA2 SPEN EP300 ZMYM3 CUX1 | 1.11e-08 | 275 | 250 | 18 | int:HNF4A |
| Interaction | SOX17 interactions | NCOA6 BCL9 CIC HOXA5 PRR12 WIZ ARID3A CHD7 ATXN1L NKX2-4 SMARCA2 | 2.68e-08 | 95 | 250 | 11 | int:SOX17 |
| Interaction | KLF8 interactions | KMT2B RREB1 CIC HOXA5 PRR12 WIZ ATXN1 SEC16A DGCR8 PRRC2A PRRC2B EP400 BICRA LARP1 CHD7 ATF7IP SPEN EP300 ZMYM3 | 3.23e-08 | 329 | 250 | 19 | int:KLF8 |
| Interaction | PRRC2B interactions | BRPF3 ANKHD1 RNF214 MEX3A ATXN1 KLF5 SEC16A PRRC2A PRRC2B RBPMS PLEKHA4 ATXN1L ACE2 OTUD4 ANKRD17 RERE EIF3F | 3.84e-08 | 265 | 250 | 17 | int:PRRC2B |
| Interaction | TLX1 interactions | RREB1 BCL9 CIC PRR12 WIZ PYGO2 ARID3A CHD7 ATXN1L ZFHX4 SMARCA2 AUTS2 EP300 CUX1 | 4.10e-08 | 175 | 250 | 14 | int:TLX1 |
| Interaction | PAX7 interactions | RREB1 BCL9 CIC PRR12 PYGO2 ATXN1 ARID3A CHD7 ATXN1L ZFHX4 SMARCA2 EP300 | 4.76e-08 | 124 | 250 | 12 | int:PAX7 |
| Interaction | SMARCA4 interactions | SREBF1 SCYL1 CHD4 SMARCAD1 TTC3 STK11IP CIC ZBTB7A MEX3A ATXN1 NR1H2 MRTFA SFPQ EP400 BICRA PLEKHA4 CHD7 RABL6 BRD4 SMARCA2 EP300 EPAS1 | 8.12e-08 | 462 | 250 | 22 | int:SMARCA4 |
| Interaction | GSC interactions | 1.25e-07 | 87 | 250 | 10 | int:GSC | |
| Interaction | SOX2 interactions | TET2 BCL9L NCOA6 MAP1A CDK12 MATR3 ZNF185 CHD4 BCL9 ANKHD1 TTC3 CIC HOXA5 PRR12 ZBTB7A WIZ PYGO2 ATXN1 KLF5 SEC16A DGCR8 MAGEC1 PRRC2B IQCE MAGED1 ARID3A EP400 GAS2L3 LARP1 CHD7 XRCC1 ECM1 ATXN1L PHC2 ZFHX4 YLPM1 SMARCA2 ANKRD17 EIF3F SPEN EP300 CUX1 | 1.28e-07 | 1422 | 250 | 42 | int:SOX2 |
| Interaction | ATXN1 interactions | KMT2B MATR3 SREBF1 OBSCN PFAS TSC1 CHD4 HSFY1 ANKHD1 CIC ACSL4 ATXN1 KLF5 TOX3 PRRC2A WNK2 PRRC2B FAM193B SFPQ RBPMS ABI1 PDCD6IP RBBP6 FOXN4 RANBP3 LARP1 PTPN23 ATXN1L MED15 SRRT ZBTB32 BRD4 EIF3F SPEN | 2.33e-07 | 1039 | 250 | 34 | int:ATXN1 |
| Interaction | BAG2 interactions | NCOA6 BRPF3 CHD4 RREB1 ANKHD1 CIC RNF214 WIZ ATXN1 AMOT EPN1 NOTCH3 MRTFA PLEKHA4 GRB10 ARHGAP17 PTPN23 STAM BRD4 EIF4G2 SHARPIN OTUD4 SPEN EP300 EPAS1 | 2.65e-07 | 622 | 250 | 25 | int:BAG2 |
| Interaction | LARP4B interactions | ANKHD1 SCAF1 ATXN1 SECISBP2 PRRC2A RBPMS MAGED1 RBBP6 PLEKHA4 LARP1 BCAR1 ATXN1L SHARPIN OTUD4 ANKRD17 | 3.45e-07 | 240 | 250 | 15 | int:LARP4B |
| Interaction | WWTR1 interactions | NCOA6 CDK12 NDN ANKHD1 WIZ SYNJ1 AMOT KLF5 AMOTL1 SEC16A PRRC2A PRRC2B ANK3 EP400 LARP1 PTPN23 LATS1 BRD4 EP300 CUX1 | 3.48e-07 | 422 | 250 | 20 | int:WWTR1 |
| Interaction | HDAC1 interactions | TET2 TGIF2 KMT2B MATR3 SREBF1 CHD4 SMARCAD1 RREB1 ANKHD1 CIC PWWP2A ZBTB7A WIZ SYNJ1 ATXN1 AMOT KLF5 MRTFA SFPQ EP400 PLEKHA4 CRTC1 SRRT TGIF1 ZFHX4 BRD4 SMARCA2 ANKRD17 CEP131 RERE SPEN EP300 EPAS1 ZMYM3 CUX1 | 3.50e-07 | 1108 | 250 | 35 | int:HDAC1 |
| Interaction | MKRN2 interactions | TGIF2 NDN PTCH1 MAGI2 RNF214 SYNJ1 SECISBP2 PRRC2A NOTCH3 PRRC2B PLEKHA4 LARP1 CHD7 SRRT SHARPIN OTUD4 CEP131 EIF3F EP300 | 3.74e-07 | 385 | 250 | 19 | int:MKRN2 |
| Interaction | ATXN1L interactions | SREBF1 MBD6 ANKHD1 CIC ATXN1 KLF5 PRRC2A PRRC2B RBPMS ATXN1L ZBTB32 SCAF11 | 3.88e-07 | 150 | 250 | 12 | int:ATXN1L |
| Interaction | ALG13 interactions | WDR33 BCL9 PRR12 SEC16A PRRC2A PRRC2B RBPMS ATXN1L LATS1 OTUD4 RERE MAPKBP1 EP300 | 5.00e-07 | 183 | 250 | 13 | int:ALG13 |
| Interaction | LHX2 interactions | BCL9L RREB1 BCL9 CIC WIZ ATXN1 MRTFA ARID3A EP400 CHD7 ZFHX4 SMARCA2 CUX1 | 5.00e-07 | 183 | 250 | 13 | int:LHX2 |
| Interaction | RBBP5 interactions | NCOA6 KMT2B WDR33 MEX3A PYGO2 KLF5 SESN2 PLEKHA4 CHD7 SRRT BRD4 ZNF335 SMARCA2 RERE SPEN EP300 | 6.50e-07 | 287 | 250 | 16 | int:RBBP5 |
| Interaction | CHD4 interactions | MATR3 CHD4 SMARCAD1 NDN HSFY1 ANKHD1 CIC PWWP2A ZBTB7A MEX3A WIZ ATXN1 SFPQ RBBP6 PLEKHA4 LARP1 MED15 RABL6 SRRT ZFHX4 MTF1 BRD4 YLPM1 EIF4G2 SMARCA2 SCAF11 EIF3F SPEN EP300 EPAS1 ZMYM3 | 6.79e-07 | 938 | 250 | 31 | int:CHD4 |
| Interaction | YWHAG interactions | TANC2 TET2 NCOA6 MAP2 CDK12 SPEG MATR3 TSC1 PRAG1 DENND2B CIC SYNJ1 ATXN1 CASKIN2 AMOT WDR20 SEC16A ABI1 PDCD6IP RANBP3 MINK1 PLEKHA4 LARP1 GRB10 ARHGAP17 CRTC1 BCAR1 MLXIP SHROOM2 UNC119 LATS1 FMN2 ANKRD17 SCAF11 CEP131 ZMYM3 SON | 7.31e-07 | 1248 | 250 | 37 | int:YWHAG |
| Interaction | MEX3B interactions | ANKHD1 RNF214 MEX3A PROSER3 SEC16A SECISBP2 PRRC2A PRRC2B VPS37C FAM193B MAGED1 BCAR1 OTUD4 ANKRD17 | 7.68e-07 | 222 | 250 | 14 | int:MEX3B |
| Interaction | CTBP1 interactions | CHD4 RREB1 CIC PRR12 WIZ ATXN1 SEC16A PRRC2B SFPQ EP400 PCLO PLEKHA4 ATXN1L MED15 ACE2 TGIF1 BRD4 SPEN EP300 | 8.34e-07 | 406 | 250 | 19 | int:CTBP1 |
| Interaction | SUPT5H interactions | WDR33 CHD4 NDN CIC SCAF4 SCAF1 RNF214 ATXN1 EP400 BICRA RANBP3 PLEKHA4 CHD7 SETD5 BRD4 SCAF11 EIF3F SPEN EP300 | 8.98e-07 | 408 | 250 | 19 | int:SUPT5H |
| Interaction | LSM14A interactions | SCYL1 PTCH1 CIC RNF214 MEX3A KLF5 SECISBP2 PRRC2A PRRC2B SFPQ TRIB2 PLEKHA4 ARHGAP17 OTUD4 ANKRD17 | 9.54e-07 | 260 | 250 | 15 | int:LSM14A |
| Interaction | PARP1 interactions | NCOA6 PNKP CHD4 SMARCAD1 NDN RREB1 MBD6 CIC SCAF1 ZBTB7A MEX3A WIZ KLF5 DGCR8 EPN1 SFPQ TRIB2 MAGED1 ARID3A PDCD6IP EP400 BICRA PLEKHA4 CHD7 XRCC1 RABL6 ACE2 ARHGAP5 MTF1 BRD4 EIF4G2 TENM1 SMARCA2 OTUD4 SCAF11 EP300 ZMYM3 CUX1 | 9.67e-07 | 1316 | 250 | 38 | int:PARP1 |
| Interaction | NFIX interactions | KMT2B RREB1 CIC PRR12 WIZ ATXN1 ARID3A EP400 BICRA ATXN1L ZFHX4 SMARCA2 SPEN CUX1 | 1.00e-06 | 227 | 250 | 14 | int:NFIX |
| Interaction | EWSR1 interactions | BCL9L NCOA6 CDK12 MATR3 NACA SREBF1 CHD4 BCL9 CIC PRR12 SEC24D WIZ AMOT DGCR8 PRRC2A SFPQ RBPMS RBBP6 BICRA MAPK1IP1L PCLO PLEKHA4 ARHGAP17 MED15 ACE2 SRRT ATF7IP BRD4 EP300 EPAS1 | 1.00e-06 | 906 | 250 | 30 | int:EWSR1 |
| Interaction | FMR1 interactions | MATR3 TSC1 CHD4 BCL9 RNF214 MEX3A SECISBP2 PRRC2A PRRC2B SFPQ MAGED1 RBBP6 PLEKHA4 LARP1 CHD7 AATK CD6 BRD4 SHARPIN OTUD4 ANKRD17 CUX1 | 1.01e-06 | 536 | 250 | 22 | int:FMR1 |
| Interaction | FUBP3 interactions | MATR3 SMARCAD1 MEX3A ATXN1 KLF5 SEC16A SECISBP2 PRRC2A PRRC2B PLEKHA4 ACE2 BRD4 YLPM1 OTUD4 ANKRD17 EP300 | 1.02e-06 | 297 | 250 | 16 | int:FUBP3 |
| Interaction | IRF4 interactions | 1.09e-06 | 85 | 250 | 9 | int:IRF4 | |
| Interaction | EN1 interactions | 1.14e-06 | 110 | 250 | 10 | int:EN1 | |
| Interaction | SIN3A interactions | TET2 BRPF3 TGIF2 SREBF1 CHD4 SMARCAD1 CIC PWWP2A ZBTB7A SFPQ PLEKHA4 TGIF1 BRD4 LRCH4 SMARCA2 EP300 EPAS1 ZMYM3 | 1.38e-06 | 380 | 250 | 18 | int:SIN3A |
| Interaction | USP9X interactions | RIN3 UBE4B MATR3 TSC1 BCL9 MEX3A MAGED4 ATXN1 AMOT AMOTL1 MAGED1 ANK3 MINK1 PLEKHA4 GRB10 NUAK2 LATS1 OTUD4 EP300 | 1.48e-06 | 422 | 250 | 19 | int:USP9X |
| Interaction | VSX1 interactions | 1.55e-06 | 66 | 250 | 8 | int:VSX1 | |
| Interaction | SRSF7 interactions | RIN3 WDR33 MATR3 SCYL1 CHD4 NDN SCAF1 ATXN1 SFPQ RBBP6 PLEKHA4 LARP1 GRB10 ACE2 SRRT BRD4 SPEN EP300 SON | 1.64e-06 | 425 | 250 | 19 | int:SRSF7 |
| Interaction | CEBPA interactions | TET2 NCOA6 KMT2B CCDC174 MATR3 CHD4 RREB1 BCL9 CIC SCAF4 PRR12 WIZ KLF5 PRRC2A PRRC2B MPP2 ATF7 SFPQ TRIB2 ARID3A EP400 BICRA LARP1 CHD7 XRCC1 ATXN1L MED15 TGIF1 BRD4 EIF4G2 SMARCA2 SHARPIN SPEN EP300 ZMYM3 CUX1 | 1.88e-06 | 1245 | 250 | 36 | int:CEBPA |
| Interaction | GCM1 interactions | 1.95e-06 | 68 | 250 | 8 | int:GCM1 | |
| Interaction | ACTC1 interactions | KMT2B CDK12 CHD4 NDN CIC SCAF4 WIZ SYNJ1 WIPF2 WNK2 MRTFA SFPQ ABI1 ARID3A PDCD6IP EP400 RBBP6 BICRA PLEKHA4 AATK BRD4 YLPM1 SMARCA2 FMN2 SON | 1.96e-06 | 694 | 250 | 25 | int:ACTC1 |
| Interaction | H2BC21 interactions | BRPF3 RIN3 PNKP KMT2B OBSCN CHD4 RREB1 FMNL2 SCAF4 PRR12 PWWP2A WIZ PRRC2A MICAL1 EP400 PCLO CC2D1B CHD7 XRCC1 PHC2 BRD4 TENM1 SCAF11 EP300 ZMYM3 | 2.06e-06 | 696 | 250 | 25 | int:H2BC21 |
| Interaction | TEAD1 interactions | RREB1 CIC PRR12 WIZ ATXN1 ARID3A CHD7 ATXN1L ZFHX4 SMARCA2 EP300 CUX1 | 2.13e-06 | 176 | 250 | 12 | int:TEAD1 |
| Interaction | SMARCC2 interactions | SCYL1 CHD4 SMARCAD1 ZBTB7A ATXN1 SFPQ RBPMS BICRA PLEKHA4 CHD7 ATXN1L RABL6 BRD4 YLPM1 SMARCA2 EP300 EPAS1 | 2.18e-06 | 353 | 250 | 17 | int:SMARCC2 |
| Interaction | ETV4 interactions | 2.18e-06 | 69 | 250 | 8 | int:ETV4 | |
| Interaction | SMC5 interactions | NCOA6 WDR33 CDK12 CCDC174 MATR3 CHD4 RREB1 CIC SCAF4 WIZ SEC16A DGCR8 PRRC2A SFPQ EP400 RBBP6 BICRA PLEKHA4 LARP1 CHD7 XRCC1 BCAR1 SRRT ATF7IP BRD4 YLPM1 EIF4G2 SCAF11 SPEN CUX1 SON | 2.59e-06 | 1000 | 250 | 31 | int:SMC5 |
| Interaction | PUM1 interactions | MATR3 PRR12 RNF214 MEX3A ATXN1 SEC16A SECISBP2 PRRC2A PRRC2B MAGED1 PLEKHA4 LATS1 OTUD4 ANKRD17 EP300 | 3.25e-06 | 287 | 250 | 15 | int:PUM1 |
| Interaction | TTC3 interactions | TSC1 TTC3 FMNL2 RNF214 MEX3A NR1H2 JADE2 SHROOM2 ATF7IP EIF4G2 | 3.41e-06 | 124 | 250 | 10 | int:TTC3 |
| Interaction | KCTD13 interactions | TANC2 CTTNBP2 MAP1A MAP2 MATR3 ZNF185 TSC1 FMNL2 MAGI2 SYNJ1 AP1G1 AMOT SEC16A SYN1 MICAL3 PRRC2A WNK2 PRRC2B MPP2 MICAL1 SFPQ ABI1 MAGED1 PDCD6IP ANK3 PRR36 PCLO MINK1 LARP1 SHROOM2 RPH3A NUAK2 SRRT ARHGAP5 EIF4G2 OTUD4 RIMBP2 SNTA1 | 3.81e-06 | 1394 | 250 | 38 | int:KCTD13 |
| Interaction | CRK interactions | ARHGAP42 RIN3 SH3BP1 NDN PRAG1 ATXN1 SYN1 PRRC2B IQCE ARAP1 MICAL1 BICRA ARHGAP17 BCAR1 PHC2 BRD4 SPEN | 4.09e-06 | 370 | 250 | 17 | int:CRK |
| Interaction | NFIA interactions | BCL9 CIC PRR12 WIZ ATXN1 KLF5 ARID3A ATXN1L MED15 SMARCA2 EP300 SON | 4.22e-06 | 188 | 250 | 12 | int:NFIA |
| Interaction | FXR1 interactions | RIN3 TSC1 ANKHD1 TTC3 RNF214 ATXN1 SEC16A SECISBP2 PRRC2A PRRC2B SFPQ ABI1 MAGED1 PLEKHA4 GRB10 ECM1 PHC2 CD6 BRD4 SHARPIN OTUD4 ANKRD17 MAPKBP1 EP300 | 4.38e-06 | 679 | 250 | 24 | int:FXR1 |
| Interaction | PRR20E interactions | 4.66e-06 | 101 | 250 | 9 | int:PRR20E | |
| Interaction | XRCC6 interactions | NCOA6 PNKP CDK12 MATR3 CHD4 SMARCAD1 NDN MBD6 CIC ZBTB7A WIZ DGCR8 ARAP1 SFPQ EP400 RBBP6 RANBP3 PLEKHA4 CHD7 XRCC1 ACE2 ARHGAP5 BRD4 YLPM1 SCAF11 SPEN SNTA1 EP300 EPAS1 | 4.79e-06 | 928 | 250 | 29 | int:XRCC6 |
| Interaction | SMC1A interactions | MATR3 SCYL1 CHD4 SMARCAD1 NDN CIC PRR12 ZBTB7A ATXN1 AMOT WNK2 PLEKHA4 ACE2 MTF1 BRD4 OTUD4 ANKRD17 EP300 | 5.23e-06 | 418 | 250 | 18 | int:SMC1A |
| Interaction | PICALM interactions | FMNL2 RNF214 SEC24D ATXN1 SEC16A MICAL3 PRRC2B RBPMS PLEKHA4 PTPN23 ATXN1L ACE2 LAMP3 TENM1 | 5.62e-06 | 263 | 250 | 14 | int:PICALM |
| Interaction | KLF3 interactions | KMT2B RREB1 MBD6 CIC WIZ ATXN1 ARID3A EP400 ATXN1L ATF7IP SMARCA2 EP300 ZMYM3 | 5.81e-06 | 228 | 250 | 13 | int:KLF3 |
| Interaction | YAP1 interactions | BCL9L NCOA6 KMT2B MAP2 WDR33 CDK12 MATR3 CHD4 PTCH1 SCAF4 AMOT KLF5 AMOTL1 SEC16A DGCR8 PRRC2A SFPQ ANK3 RBBP6 RANBP3 LARP1 MED15 COL18A1 LATS1 BRD4 YLPM1 SMARCA2 SHARPIN EIF3F SPEN EP300 CUX1 | 6.00e-06 | 1095 | 250 | 32 | int:YAP1 |
| Interaction | PFN1 interactions | MAP1A TSC1 NDN ANKHD1 FMNL2 SYNJ1 SEC16A MICAL3 WIPF2 MRTFA SFPQ ABI1 PCLO PLEKHA4 ARHGAP17 UNC119 ACE2 ARHGAP5 FMN2 CEP131 | 6.14e-06 | 509 | 250 | 20 | int:PFN1 |
| Interaction | SMARCC1 interactions | SREBF1 SCYL1 CHD4 SMARCAD1 STK11IP CIC SFPQ BICRA PLEKHA4 CHD7 RABL6 LATS1 BRD4 YLPM1 SMARCA2 EP300 EPAS1 | 6.69e-06 | 384 | 250 | 17 | int:SMARCC1 |
| Interaction | CNOT9 interactions | ANKHD1 RNF214 SEC16A PRRC2A PRRC2B MAGED1 MINK1 PLEKHA4 GRB10 AATK OTUD4 ANKRD17 CEP131 | 6.69e-06 | 231 | 250 | 13 | int:CNOT9 |
| Interaction | DDX17 interactions | RIN3 MATR3 CHD4 SMARCAD1 NDN MBD6 CIC MEX3A ATXN1 DGCR8 SFPQ PLEKHA4 ACE2 MTF1 BRD4 YLPM1 SPEN EP300 | 6.79e-06 | 426 | 250 | 18 | int:DDX17 |
| Interaction | YWHAZ interactions | TANC2 TET2 RIN3 MAP2 SPEG MATR3 PFAS TSC1 DENND2B CIC ATXN1 NBEAL2 AMOTL1 WDR20 SYN1 PRRC2A WNK2 SFPQ ABI1 MINK1 PLEKHA4 LARP1 GRB10 CRTC1 BCAR1 MLXIP NUAK2 ACE2 LATS1 CSF2RB BRD4 OTUD4 ANKRD17 SCAF11 CEP131 EP300 | 6.90e-06 | 1319 | 250 | 36 | int:YWHAZ |
| Interaction | FXR2 interactions | TSC1 CHD4 NDN RNF214 PRRC2A PRRC2B SFPQ RBPMS MAGED1 PLEKHA4 PHC2 AATK LATS1 CD6 BRD4 OTUD4 ANKRD17 MAPKBP1 | 7.71e-06 | 430 | 250 | 18 | int:FXR2 |
| Interaction | PRRC2A interactions | PTCH1 MEX3A ATXN1 KLF5 SEC16A SECISBP2 PRRC2A PRRC2B SFPQ MAGED1 PLEKHA4 ATXN1L BRD4 OTUD4 ANKRD17 RERE EIF3F | 7.92e-06 | 389 | 250 | 17 | int:PRRC2A |
| Interaction | SOX7 interactions | 8.10e-06 | 82 | 250 | 8 | int:SOX7 | |
| Interaction | PRR20A interactions | 8.73e-06 | 109 | 250 | 9 | int:PRR20A | |
| Interaction | YTHDF2 interactions | RIN3 CIC RNF214 MEX3A SECISBP2 PRRC2A PRRC2B SFPQ PLEKHA4 PTPN23 ACE2 EIF4G2 OTUD4 ANKRD17 EPAS1 | 8.90e-06 | 312 | 250 | 15 | int:YTHDF2 |
| Interaction | ARID1A interactions | CCDC174 SCYL1 CHD4 TTC3 STK11IP ZBTB7A MEX3A ATXN1 KLF5 BICRA PLEKHA4 CHD7 SMARCA2 EP300 | 9.73e-06 | 276 | 250 | 14 | int:ARID1A |
| Interaction | SH3KBP1 interactions | RIN3 SH3BP1 SEC24D SYNJ1 CASKIN2 WIPF2 PRRC2A ARAP1 SFPQ PDCD6IP HCN1 ARHGAP17 BCAR1 RPH3A AATK | 9.97e-06 | 315 | 250 | 15 | int:SH3KBP1 |
| Interaction | PAX2 interactions | 1.06e-05 | 85 | 250 | 8 | int:PAX2 | |
| Interaction | SMG7 interactions | NCOA6 BCL9 PRR12 RNF214 AMOT SEC16A SECISBP2 PRRC2A PRRC2B ARID3A PLEKHA4 LATS1 YLPM1 OTUD4 ANKRD17 | 1.16e-05 | 319 | 250 | 15 | int:SMG7 |
| Interaction | CSNK2B interactions | RIN3 KMT2B CHD4 CIC WIZ ATXN1 MICAL3 NOTCH3 MPP2 MICAL1 EP400 MINK1 PLEKHA4 XRCC1 PHC2 NUAK2 ACE2 BRD4 TENM1 AUTS2 EIF3F EP300 | 1.19e-05 | 625 | 250 | 22 | int:CSNK2B |
| Interaction | CIC interactions | TGIF2 MATR3 CHD4 RREB1 CIC HOXA5 ZBTB7A WIZ ATXN1 KLF5 ATF7 SFPQ EP400 LARP1 CHD7 ATXN1L SRRT ZFHX4 NKX2-4 OTUD4 EIF3F CUX1 SON | 1.20e-05 | 673 | 250 | 23 | int:CIC |
| Interaction | MEN1 interactions | NCOA6 KMT2B UBE4B WDR33 MATR3 SCYL1 CHD4 SMARCAD1 PRR12 WIZ PRRC2A ATF7 SFPQ EP400 RBBP6 JADE2 RANBP3 PLEKHA4 LARP1 XRCC1 SRRT ARHGAP5 YLPM1 ANKRD17 SCAF11 RERE SPEN ZMYM3 CUX1 SON | 1.26e-05 | 1029 | 250 | 30 | int:MEN1 |
| Interaction | NAA40 interactions | MAP1A CDK12 MATR3 NACA PFAS TSC1 CHD4 ANKHD1 CIC SCAF4 WIZ SYNJ1 NAF1 SEC16A PRRC2A PRRC2B FAM193B SFPQ EP400 RBBP6 RANBP3 LARP1 PTPN23 STAM ATF7IP YLPM1 EIF4G2 ANKRD17 SON | 1.30e-05 | 978 | 250 | 29 | int:NAA40 |
| Interaction | NFIC interactions | TET2 RREB1 CIC PRR12 WIZ ATXN1 ARID3A ATXN1L BRD4 SMARCA2 SCAF11 CUX1 | 1.30e-05 | 210 | 250 | 12 | int:NFIC |
| Interaction | RBFOX2 interactions | MATR3 ANKHD1 HOXA5 ATXN1 NAF1 PRRC2A PRRC2B RBPMS MAGED1 MAPK1IP1L PLEKHA4 ATXN1L OTUD4 RERE | 1.34e-05 | 284 | 250 | 14 | int:RBFOX2 |
| Interaction | PRMT1 interactions | TET2 RIN3 UBE4B WDR33 SPEG MATR3 NACA SCYL1 NDN PTCH1 WIZ ATXN1 SEC16A DGCR8 PRRC2A PRRC2B SFPQ PLEKHA4 LARP1 CC2D1B ACE2 SRRT BRD4 YLPM1 OTUD4 SCAF11 EIF3F EP300 | 1.38e-05 | 929 | 250 | 28 | int:PRMT1 |
| Interaction | CPEB1 interactions | MAP2 MATR3 ANKHD1 RNF214 PRRC2A PRRC2B MAGED1 LARP1 OTUD4 ANKRD17 | 1.46e-05 | 146 | 250 | 10 | int:CPEB1 |
| GeneFamily | Variable charge X/Y family | 3.66e-10 | 6 | 166 | 5 | 368 | |
| GeneFamily | Ankyrin repeat domain containing | 4.07e-04 | 242 | 166 | 9 | 403 | |
| GeneFamily | MAGE family | 4.84e-04 | 40 | 166 | 4 | 1136 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.14e-03 | 50 | 166 | 4 | 721 | |
| GeneFamily | PHD finger proteins | 1.44e-03 | 90 | 166 | 5 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.51e-03 | 25 | 166 | 3 | 775 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.89e-03 | 9 | 166 | 2 | 1230 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | SH3BP1 REXO1 CIC SCAF1 RNF214 EPN1 PRRC2A RBBP6 BICRA RANBP3 MINK1 LARP1 ARHGAP17 CC2D1B SRRT SETD5 LRCH4 NEURL4 CAPN15 | 1.21e-09 | 338 | 257 | 19 | M17094 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ARHGAP42 TANC2 TET2 MAP1A NBEAL1 SPEG CHD4 ANKHD1 STK11IP PRAG1 FMNL2 SCAF4 TSC22D1 MICAL3 ZNF579 PLXNB3 IQCE MPP2 ATMIN ABI1 ANK3 RBBP6 SOCS3 BCAR1 SHROOM2 ARHGAP5 AATK YLPM1 SMARCA2 FMN2 | 4.74e-07 | 1102 | 257 | 30 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ARHGAP42 TANC2 TET2 MAP1A NBEAL1 SPEG CHD4 ANKHD1 STK11IP PRAG1 FMNL2 SCAF4 TSC22D1 MICAL3 ZNF579 PLXNB3 IQCE MPP2 ATMIN ABI1 ANK3 RBBP6 SOCS3 BCAR1 SHROOM2 ARHGAP5 AATK YLPM1 SMARCA2 FMN2 | 7.15e-07 | 1124 | 257 | 30 | MM1070 |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN | BCL9L TGIF2 PEX13 DENND2B DNALI1 RNF214 SEC24D FAF2 P3H3 ZFHX4 ANKRD17 | 4.94e-06 | 200 | 257 | 11 | M9311 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | PFAS CHD4 ATXN1 AMOT SEC16A NOTCH3 MAGED1 EP400 P3H3 RBBP6 SCAF11 EP300 | 1.99e-05 | 276 | 257 | 12 | M3063 |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP | 2.24e-05 | 193 | 257 | 10 | M9975 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | TANC2 MBD6 REXO1 SECISBP2 MICAL3 FAM193B MINK1 CC2D1B ADAMTSL5 | 2.24e-05 | 154 | 257 | 9 | M6824 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 2.91e-05 | 199 | 257 | 10 | MM991 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 2.91e-05 | 199 | 257 | 10 | M2155 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 3.04e-05 | 200 | 257 | 10 | M302 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | ZNF142 STK11IP RNF214 SLC35A4 AGFG2 ATMIN MICAL1 ATXN1L ZFYVE26 CAPN15 | 3.04e-05 | 200 | 257 | 10 | M6208 |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_UP | BCL9L NBEAL1 STK11IP ARAP1 ABI1 CRTC1 CC2D1B ATF7IP MAPKBP1 NEURL4 | 3.04e-05 | 200 | 257 | 10 | M3153 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | OBSCN STK11IP CIC MICAL1 FAM193B ANK3 PCLO PRRT2 RABL6 COL18A1 SMARCA2 AUTS2 RIMBP2 RERE | 3.37e-05 | 389 | 257 | 14 | M39102 |
| Coexpression | WANG_CLIM2_TARGETS_UP | WDR33 CIC SCAF4 ZBTB7A PROSER3 ARAP1 SFPQ AOC2 E2F2 COL18A1 ZMYM3 | 7.92e-05 | 270 | 257 | 11 | M10334 |
| Coexpression | BORCZUK_MALIGNANT_MESOTHELIOMA_DN | 8.57e-05 | 106 | 257 | 7 | M7988 | |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN | 9.35e-05 | 185 | 257 | 9 | M9014 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | WDR33 CDK12 ZBTB7A AP1G1 WDR20 SFPQ RBBP6 MAPK1IP1L CHD7 STAM ATXN1L CD6 SCAF11 SON | 1.03e-04 | 432 | 257 | 14 | M41149 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CTTNBP2 NBEAL1 SPEG ZNF185 RREB1 FMNL2 DENND2B ACSL4 MAGI2 AMOTL1 RBPMS TRIB2 AKIRIN1 RBBP6 ARHGAP17 SHROOM2 ARHGAP5 TMTC1 EP300 EPAS1 SON | 1.15e-04 | 854 | 257 | 21 | M1533 |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN | 1.45e-04 | 196 | 257 | 9 | M6174 | |
| Coexpression | FALVELLA_SMOKERS_WITH_LUNG_CANCER | 1.47e-04 | 81 | 257 | 6 | M18536 | |
| Coexpression | GSE3982_DC_VS_BCELL_DN | 1.50e-04 | 197 | 257 | 9 | M5470 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 1.53e-04 | 155 | 257 | 8 | M8944 | |
| Coexpression | GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 1.62e-04 | 199 | 257 | 9 | M8538 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP | 1.62e-04 | 199 | 257 | 9 | M9077 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | 1.62e-04 | 199 | 257 | 9 | M3156 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN | ARHGAP42 ZNF142 UBE4B WDR33 DENND2B RNF214 SEC24D ZNF579 RBPMS | 1.69e-04 | 200 | 257 | 9 | M3547 |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 1.69e-04 | 200 | 257 | 9 | M7283 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 1.69e-04 | 200 | 257 | 9 | M5069 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_DC_DN | 1.69e-04 | 200 | 257 | 9 | M4484 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 1.92e-04 | 85 | 257 | 6 | M1723 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 1.92e-04 | 85 | 257 | 6 | MM720 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TANC2 NCOA6 KMT2B TSC1 SEC24D TSC22D1 KLF5 WIPF2 PRRC2B MRTFA SFPQ ABI1 GRB10 STAM MTF1 SETD5 ATF7IP BRD4 EP300 CUX1 | 1.93e-04 | 822 | 257 | 20 | M6782 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CTTNBP2 NBEAL1 SPEG ZNF185 RREB1 FMNL2 DENND2B ACSL4 MAGI2 AMOTL1 RBPMS TRIB2 AKIRIN1 RBBP6 ARHGAP17 SHROOM2 ARHGAP5 TMTC1 EP300 EPAS1 SON | 1.96e-04 | 888 | 257 | 21 | MM1018 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.06e-04 | 162 | 257 | 8 | M45037 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | BRPF3 MAP1A MAP2 LRFN3 KLF14 PEX13 TSC1 SMARCAD1 PTCH1 BCL9 TTC3 FMNL2 SORCS1 SYNJ1 TOX3 AGFG2 ZNF579 KLHL14 WNK2 GAS2L3 PRR36 ARHGAP17 E2F2 CHD7 SHROOM2 PHC2 NUAK2 TMTC1 SETD5 BRD4 EIF4G2 AUTS2 PALM3 RERE SNTA1 CUX1 | 7.28e-06 | 1370 | 254 | 36 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | TANC2 BCL9 CIC WIZ FAF2 SLC35A4 IQCE ATF7 VPS37C ABI1 LARP1 STAM TMEM209 | 1.66e-10 | 200 | 256 | 13 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.60e-07 | 200 | 256 | 10 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-06 | 133 | 256 | 8 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.17e-06 | 135 | 256 | 8 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 187 | 256 | 9 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 192 | 256 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 193 | 256 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 195 | 256 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 195 | 256 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.72e-06 | 167 | 256 | 8 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 171 | 256 | 8 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 171 | 256 | 8 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 171 | 256 | 8 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-06 | 173 | 256 | 8 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-06 | 173 | 256 | 8 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.36e-06 | 128 | 256 | 7 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 256 | 8 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 256 | 8 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 256 | 8 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-05 | 186 | 256 | 8 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-05 | 188 | 256 | 8 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.36e-05 | 188 | 256 | 8 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 188 | 256 | 8 | 921a2c9212a0f2a00fd72c594d80924f27e8b9b7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-05 | 189 | 256 | 8 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.47e-05 | 190 | 256 | 8 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 190 | 256 | 8 | 96a9756cad5468a12591021e6d661ed269b5b3d9 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.47e-05 | 190 | 256 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.52e-05 | 191 | 256 | 8 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 192 | 256 | 8 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.58e-05 | 192 | 256 | 8 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | background-Cholangiocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-05 | 193 | 256 | 8 | 9152241073dbe02ac2c11d86bec9b5b529196f6e | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.70e-05 | 194 | 256 | 8 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 194 | 256 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-05 | 194 | 256 | 8 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 197 | 256 | 8 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 197 | 256 | 8 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 197 | 256 | 8 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.90e-05 | 197 | 256 | 8 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg|ICU-SEP / Disease, condition lineage and cell class | 1.90e-05 | 197 | 256 | 8 | c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.97e-05 | 198 | 256 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.05e-05 | 199 | 256 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.05e-05 | 199 | 256 | 8 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.12e-05 | 200 | 256 | 8 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.12e-05 | 200 | 256 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.12e-05 | 200 | 256 | 8 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.12e-05 | 200 | 256 | 8 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-05 | 200 | 256 | 8 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 200 | 256 | 8 | ed941933457f8bf63b277025286ef0485e78f4d0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.51e-05 | 149 | 256 | 7 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.85e-05 | 152 | 256 | 7 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 160 | 256 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 160 | 256 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 163 | 256 | 7 | 7a04192710f55acf5a4681d5f09942358fdb02ff | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.00e-05 | 166 | 256 | 7 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.20e-05 | 167 | 256 | 7 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.20e-05 | 167 | 256 | 7 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-05 | 169 | 256 | 7 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.81e-05 | 170 | 256 | 7 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.03e-05 | 171 | 256 | 7 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.03e-05 | 171 | 256 | 7 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-05 | 173 | 256 | 7 | 28c98a9a54aa2cfa67464db4f628c9357ad185b9 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 6.80e-05 | 120 | 256 | 6 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.49e-05 | 177 | 256 | 7 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-05 | 178 | 256 | 7 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.04e-05 | 179 | 256 | 7 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.04e-05 | 179 | 256 | 7 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.62e-05 | 181 | 256 | 7 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.92e-05 | 182 | 256 | 7 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-05 | 182 | 256 | 7 | f5f42e23832d0210560009ce6fd8eee89751e252 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 8.92e-05 | 182 | 256 | 7 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-05 | 182 | 256 | 7 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-05 | 183 | 256 | 7 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.23e-05 | 183 | 256 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-05 | 183 | 256 | 7 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 184 | 256 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 184 | 256 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 184 | 256 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-CD4-naive_CD4|COVID / Condition, Cell_class and T cell subcluster | 9.55e-05 | 184 | 256 | 7 | 00db55970d336a301035efe43a4ab4db62627f38 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.88e-05 | 185 | 256 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.88e-05 | 185 | 256 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 9.88e-05 | 185 | 256 | 7 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 186 | 256 | 7 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-04 | 186 | 256 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.02e-04 | 186 | 256 | 7 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-04 | 187 | 256 | 7 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.06e-04 | 187 | 256 | 7 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 188 | 256 | 7 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 188 | 256 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 188 | 256 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.09e-04 | 188 | 256 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-04 | 190 | 256 | 7 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 1.17e-04 | 190 | 256 | 7 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 191 | 256 | 7 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 191 | 256 | 7 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 191 | 256 | 7 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | facs-Pancreas-Endocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 191 | 256 | 7 | b3de0393d6510543533cd851e47a0f95739a0e4e | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 191 | 256 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 191 | 256 | 7 | 657297cd19d05a7e7bb74fc3a086fbd95f47aae4 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 192 | 256 | 7 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-04 | 192 | 256 | 7 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | LRFN3 HOXB2 AGFG2 FGD1 MICAL3 MMP15 WIPF2 MRTFA ARAP1 JADE2 RANBP3 MINK1 CRTC1 AUTS2 RERE | 6.74e-09 | 196 | 256 | 15 | 3383_DN |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | BCL9 ZBTB7A WIZ FGD1 WIPF2 VGF MPP2 TRIB2 MINK1 CRTC1 MLXIP CD6 SNTA1 | 4.14e-07 | 198 | 256 | 13 | 2281_DN |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | SH3BP1 CIC CASKIN2 MMP15 PRRC2A NOTCH3 PRRC2B VGF VPS37C COL18A1 RERE CAPN15 | 2.06e-06 | 193 | 256 | 12 | 3262_UP |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | MAP1A DGCR8 MMP15 ARAP1 MICAL1 TRIB2 PRR36 SOCS3 MLXIP ZFHX4 SNTA1 CAPN15 | 2.17e-06 | 194 | 256 | 12 | 4169_DN |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | TANC2 PTCH1 HOXB2 ALPK3 DGCR8 VGF RBPMS RANBP3 MINK1 AOC2 EIF4G2 RERE | 2.42e-06 | 196 | 256 | 12 | 3726_DN |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 2.71e-06 | 104 | 256 | 9 | ctd:C000595015 | |
| Drug | 5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA | PTCH1 DNALI1 WIZ MMP15 MPP2 PRR36 BICRA RANBP3 PCDHA5 UNC119 CD6 TMEM209 | 2.83e-06 | 199 | 256 | 12 | 900_DN |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | SREBF1 DENND2B CIC DNALI1 ROBO3 MMP15 PRRC2A ARAP1 MPP2 PRR36 MINK1 CAPN15 | 2.98e-06 | 200 | 256 | 12 | 3322_UP |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | NCOA6 KMT2B CDK12 NACA RREB1 DGCR8 JADE2 TGIF1 SCAF11 EP300 CAPN15 | 4.69e-06 | 174 | 256 | 11 | 1659_DN |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | TGIF2 ZBTB7A DGCR8 RBBP6 MLXIP SRRT TGIF1 YLPM1 ZFYVE26 SPEN ZMYM3 | 8.00e-06 | 184 | 256 | 11 | 1064_DN |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.32e-05 | 194 | 256 | 11 | 3969_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | MAP1A CASKIN2 DGCR8 VGF TRIB2 PRR36 RPH3A UNC119 LATS1 CD6 TMEM209 | 1.32e-05 | 194 | 256 | 11 | 4174_DN |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A | RIN3 ZBTB7A SYNJ1 CASKIN2 KLF5 NBEAL2 TRIB2 SRRT BRD4 LAMP3 RERE | 1.38e-05 | 195 | 256 | 11 | 5618_DN |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | SREBF1 NBEAL2 SECISBP2 MMP15 WIPF2 NOTCH3 VGF MPP2 BRD4 SMARCA2 MAPKBP1 | 1.38e-05 | 195 | 256 | 11 | 7225_DN |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | UBE4B BCL9 ACSL4 ZBTB7A MMP15 ARAP1 MICAL1 RANBP3 EIF4G2 TMEM209 EP300 | 1.38e-05 | 195 | 256 | 11 | 2852_DN |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | ZNF142 MAP1A SCAF4 SEC24D CASKIN2 MPP2 ECM1 SRRT AATK BRD4 CAPN15 | 1.45e-05 | 196 | 256 | 11 | 6610_DN |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; PC3; HT_HG-U133A | SEC24D WIZ NBEAL2 NOTCH3 CCNJL RBPMS MINK1 SRRT CD6 EIF4G2 CAPN15 | 1.45e-05 | 196 | 256 | 11 | 4204_DN |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | SCAF4 SEC24D FGD1 DGCR8 IQCE RBPMS PRR36 MINK1 UNC119 EIF4G2 CAPN15 | 1.52e-05 | 197 | 256 | 11 | 5449_DN |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | CIC ZBTB7A CASKIN2 MMP15 VGF ANK3 MINK1 RABL6 SRRT EIF4G2 CAPN15 | 1.52e-05 | 197 | 256 | 11 | 7201_DN |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | UBE4B SREBF1 SCAF4 AGFG2 IQCE CCNJL SFPQ RBPMS ABI1 RANBP3 ARHGAP17 | 1.52e-05 | 197 | 256 | 11 | 7286_DN |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | TGIF2 MAP1A DGCR8 ARAP1 MICAL1 PRR36 JADE2 RANBP3 PCDHA5 TMEM209 LTBP2 | 1.52e-05 | 197 | 256 | 11 | 7500_UP |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | KMT2B UBE4B BCL9 CIC PRRC2B BICRA MED15 BRD4 YLPM1 SHARPIN CAPN15 | 1.52e-05 | 197 | 256 | 11 | 1697_DN |
| Drug | Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A | BCL9 DNALI1 NBEAL2 DGCR8 MRTFA ARAP1 VGF MICAL1 UNC119 SRRT CD6 | 1.52e-05 | 197 | 256 | 11 | 2275_DN |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | SREBF1 CHD4 BCL9 CIC PRRC2B IQCE MICAL1 ARID3A PRR36 BRD4 RERE | 1.52e-05 | 197 | 256 | 11 | 2766_UP |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | RIN3 ZBTB7A CASKIN2 NOTCH3 PRRC2B MRTFA RANBP3 SOCS3 CRTC1 AUTS2 OTUD4 | 1.60e-05 | 198 | 256 | 11 | 2320_DN |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A | SPEG SREBF1 DNALI1 SYNJ1 CASKIN2 DGCR8 WIPF2 MRTFA CCNJL CRTC1 OTUD4 | 1.60e-05 | 198 | 256 | 11 | 3286_UP |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; HL60; HT_HG-U133A | RIN3 TGIF2 ZNF142 PEX13 CIC ZBTB7A ATXN1 WIPF2 EP400 BICRA ZNF335 | 1.67e-05 | 199 | 256 | 11 | 1319_DN |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | ZNF142 KMT2B TSC1 CIC SCAF4 WIZ PRRC2B MRTFA EP400 SOCS3 MAPKBP1 | 1.67e-05 | 199 | 256 | 11 | 578_UP |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 2.91e-05 | 174 | 256 | 10 | 1302_UP | |
| Drug | Magnetite Nanoparticles | TET2 NBEAL1 CDK12 MATR3 ZNF185 CHD4 TTC3 ACSL4 MAGI2 ZBTB7A TSC22D1 ATXN1 AGFG2 SYN1 SFPQ ARID3A PDCD6IP ANK3 RBBP6 JADE2 MAPK1IP1L SOCS3 E2F2 NUAK2 COL18A1 ZBTB32 ZFHX4 MTF1 OTUD4 SNTA1 ZMYM3 CUX1 | 3.11e-05 | 1310 | 256 | 32 | ctd:D058185 |
| Drug | Succimer | TET2 NBEAL1 CDK12 MATR3 ZNF185 CHD4 TTC3 ACSL4 MAGI2 ZBTB7A TSC22D1 ATXN1 AGFG2 SYN1 SFPQ PDCD6IP ANK3 RBBP6 JADE2 MAPK1IP1L SOCS3 E2F2 NUAK2 COL18A1 ZBTB32 ZFHX4 MTF1 OTUD4 SNTA1 ZMYM3 CUX1 | 3.87e-05 | 1264 | 256 | 31 | ctd:D004113 |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | ZBTB7A DGCR8 NOTCH3 FAM193B RBPMS RBBP6 MLXIP TGIF1 ZFYVE26 RERE | 6.40e-05 | 191 | 256 | 10 | 1057_DN |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 6.69e-05 | 192 | 256 | 10 | 4152_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 6.99e-05 | 193 | 256 | 10 | 3200_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 6.99e-05 | 193 | 256 | 10 | 4245_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 6.99e-05 | 193 | 256 | 10 | 3973_DN | |
| Drug | 1q1g | 7.28e-05 | 39 | 256 | 5 | CID000447992 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | ZNF142 KMT2B SREBF1 PFAS ACSL4 ATXN1 SECISBP2 PRRC2A RANBP3 SRRT | 7.30e-05 | 194 | 256 | 10 | 2523_DN |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | CIC ZBTB7A CASKIN2 MICAL3 IQCE MICAL1 RANBP3 MINK1 UNC119 YLPM1 | 7.30e-05 | 194 | 256 | 10 | 1707_DN |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A | 7.30e-05 | 194 | 256 | 10 | 1422_UP | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | KMT2B SCAF4 CASKIN2 MICAL3 PRR36 RANBP3 MINK1 SHARPIN RERE CAPN15 | 7.30e-05 | 194 | 256 | 10 | 5384_DN |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A | LILRB1 WIZ WIPF2 EP400 RANBP3 LARP1 SHARPIN CEP131 SPEN CAPN15 | 7.62e-05 | 195 | 256 | 10 | 1296_DN |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 7.62e-05 | 195 | 256 | 10 | 3078_UP | |
| Drug | Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | LRFN3 PTCH1 WIZ MMP15 PRRC2A IQCE RANBP3 UNC119 EIF4G2 ZFYVE26 | 7.62e-05 | 195 | 256 | 10 | 7198_DN |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | KMT2B WIZ CASKIN2 NOTCH3 PRRC2B BICRA GRB10 XRCC1 MED15 MAPKBP1 | 7.62e-05 | 195 | 256 | 10 | 3408_DN |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.62e-05 | 195 | 256 | 10 | 4398_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | WIZ MICAL3 MICAL1 MINK1 CRTC1 UNC119 AATK BRD4 TMEM209 MAPKBP1 | 7.95e-05 | 196 | 256 | 10 | 1479_UP |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 7.95e-05 | 196 | 256 | 10 | 4125_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | ZBTB7A CASKIN2 ROBO3 RANBP3 MINK1 MED15 SRRT CD6 RERE CAPN15 | 7.95e-05 | 196 | 256 | 10 | 4227_DN |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A | KMT2B DNALI1 ZBTB7A SEC24D TRIB2 JADE2 RANBP3 PCLO SNTA1 EPAS1 | 7.95e-05 | 196 | 256 | 10 | 4723_DN |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A | WDR33 DENND2B WIZ CASKIN2 NOTCH3 MRTFA MICAL1 ARHGAP17 RPH3A CAPN15 | 8.29e-05 | 197 | 256 | 10 | 4158_DN |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 8.29e-05 | 197 | 256 | 10 | 2716_DN | |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 8.29e-05 | 197 | 256 | 10 | 2759_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | TSC1 WIZ NBEAL2 PRRC2A FAM193B RANBP3 GRB10 BRD4 ZNF335 SHARPIN | 8.29e-05 | 197 | 256 | 10 | 3425_DN |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | LRFN3 BCL9 CIC GID4 SECISBP2 MICAL3 RANBP3 SRRT MAPKBP1 CAPN15 | 8.29e-05 | 197 | 256 | 10 | 7231_DN |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.29e-05 | 197 | 256 | 10 | 2262_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | SPEG DENND2B CASKIN2 FGD1 SECISBP2 WIPF2 IQCE MTF1 ZNF335 CEP131 | 8.65e-05 | 198 | 256 | 10 | 2068_DN |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 8.65e-05 | 198 | 256 | 10 | 3405_UP | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 8.65e-05 | 198 | 256 | 10 | 3738_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A | KMT2B BCL9 ACSL4 WIZ NOTCH3 ARAP1 MINK1 SHROOM2 YLPM1 TMEM209 | 8.65e-05 | 198 | 256 | 10 | 3581_DN |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | RIN3 SPEG LRFN3 CASKIN2 NBEAL2 NOTCH3 IQCE MINK1 TENM1 CAPN15 | 8.65e-05 | 198 | 256 | 10 | 7310_DN |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.65e-05 | 198 | 256 | 10 | 3626_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | TGIF2 LRFN3 BCL9 KLF5 MPP2 SHROOM2 MTF1 BRD4 SMARCA2 MAPKBP1 | 8.65e-05 | 198 | 256 | 10 | 1690_DN |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | WDR33 LRFN3 ZBTB7A FGD1 MRTFA PRR36 RANBP3 MINK1 SHARPIN RERE | 8.65e-05 | 198 | 256 | 10 | 3843_DN |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | CASKIN2 NOTCH3 VGF MICAL1 FAM193B RANBP3 MINK1 GRB10 SMARCA2 EP300 | 8.65e-05 | 198 | 256 | 10 | 3554_DN |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; PC3; HT_HG-U133A | 8.65e-05 | 198 | 256 | 10 | 4203_DN | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A | AGFG2 WIPF2 ARAP1 MPP2 RBPMS ANK3 RANBP3 CRTC1 TMEM209 AUTS2 | 8.65e-05 | 198 | 256 | 10 | 3264_DN |
| Drug | Tolazamide [1156-19-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A | WDR33 CIC ZBTB7A MMP15 MPP2 MINK1 CRTC1 SHROOM2 EIF4G2 TMEM209 | 8.65e-05 | 198 | 256 | 10 | 2842_DN |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | TGIF2 ZBTB7A NBEAL2 PRRC2B VGF RBPMS XRCC1 MLXIP MED15 ZNF335 | 9.02e-05 | 199 | 256 | 10 | 7192_DN |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | TGIF2 ZBTB7A WIZ PRRC2A MPP2 ARID3A RANBP3 GRB10 COL18A1 SMARCA2 | 9.02e-05 | 199 | 256 | 10 | 7203_DN |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A | KMT2B LILRB1 NBEAL2 NR1H2 MICAL3 IQCE CD6 ZNF335 LTBP2 CAPN15 | 9.02e-05 | 199 | 256 | 10 | 2404_DN |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; MCF7; HT_HG-U133A | KMT2B WDR33 ZBTB7A CASKIN2 GID4 RANBP3 MINK1 RPH3A MED15 SMARCA2 | 9.02e-05 | 199 | 256 | 10 | 7016_UP |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 9.02e-05 | 199 | 256 | 10 | 2257_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | SCAF4 CASKIN2 ROBO3 MRTFA FAM193B SFPQ RPH3A BRD4 TMEM209 EP300 | 9.02e-05 | 199 | 256 | 10 | 1811_UP |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | ACSL4 SEC24D FGD1 MICAL3 NOTCH3 ARAP1 BICRA CRTC1 NUAK2 SMARCA2 | 9.02e-05 | 199 | 256 | 10 | 7246_UP |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A | WDR33 DENND2B ZBTB7A NOTCH3 IQCE MICAL1 RANBP3 MINK1 EIF4G2 RERE | 9.02e-05 | 199 | 256 | 10 | 2855_DN |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | SEC24D CASKIN2 MMP15 NOTCH3 MRTFA MICAL1 CRTC1 SHROOM2 ZFYVE26 CAPN15 | 9.02e-05 | 199 | 256 | 10 | 1702_DN |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | TGIF2 UBE4B SPEG CASKIN2 NBEAL2 WIPF2 MRTFA ARAP1 GRB10 SRRT | 9.02e-05 | 199 | 256 | 10 | 7254_DN |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; PC3; HT_HG-U133A | SPEG SEC24D SECISBP2 EPN1 ARAP1 RBPMS ARID3A AATK RIMBP2 CAPN15 | 9.40e-05 | 200 | 256 | 10 | 3991_DN |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A | 1.31e-04 | 169 | 256 | 9 | 2193_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.49e-04 | 172 | 256 | 9 | 1072_DN | |
| Drug | Ethacrynic acid [58-54-8]; Up 200; 13.2uM; HL60; HG-U133A | 2.79e-04 | 187 | 256 | 9 | 1565_UP | |
| Drug | Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.01e-04 | 189 | 256 | 9 | 4998_UP | |
| Drug | TTNPB; Up 200; 0.1uM; MCF7; HG-U133A | 3.13e-04 | 190 | 256 | 9 | 223_UP | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.13e-04 | 190 | 256 | 9 | 2619_UP | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.26e-04 | 191 | 256 | 9 | 2789_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.26e-04 | 191 | 256 | 9 | 5204_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; PC3; HT_HG-U133A | 3.38e-04 | 192 | 256 | 9 | 6664_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; PC3; HT_HG-U133A | 3.38e-04 | 192 | 256 | 9 | 6353_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.51e-04 | 193 | 256 | 9 | 3258_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A | 3.51e-04 | 193 | 256 | 9 | 4186_DN | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 3.51e-04 | 193 | 256 | 9 | 948_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 3.51e-04 | 193 | 256 | 9 | 4321_DN | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A | 3.51e-04 | 193 | 256 | 9 | 2078_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 3.51e-04 | 193 | 256 | 9 | 5024_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.65e-04 | 194 | 256 | 9 | 2311_UP | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.65e-04 | 194 | 256 | 9 | 1804_DN | |
| Drug | Imidurea [39236-46-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.65e-04 | 194 | 256 | 9 | 5062_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.65e-04 | 194 | 256 | 9 | 4126_DN | |
| Drug | paclitaxel; Down 200; 0.1uM; MCF7; HG-U133A | 3.65e-04 | 194 | 256 | 9 | 640_DN | |
| Disease | neuroimaging measurement | CTTNBP2 KMT2B MAP2 NBEAL1 SMARCAD1 COL22A1 RREB1 PTCH1 MBD6 ZNF469 SYNJ1 PROSER3 TOX3 ROBO3 WNK2 MPP2 ANK3 GRB10 CHD7 STAM COL18A1 ZBTB32 LRCH4 SMARCA2 RERE | 5.43e-06 | 1069 | 251 | 25 | EFO_0004346 |
| Disease | brain measurement, neuroimaging measurement | RIN3 CTTNBP2 MAP2 RREB1 PTCH1 MBD6 TOX3 WNK2 MPP2 ANK3 GRB10 COL18A1 ZBTB32 LATS1 LRCH4 SMARCA2 | 2.23e-05 | 550 | 251 | 16 | EFO_0004346, EFO_0004464 |
| Disease | cortical thickness | RIN3 CTTNBP2 KMT2B NBEAL1 SREBF1 SMARCAD1 RREB1 PTCH1 MBD6 FMNL2 ZNF469 TOX3 MICAL3 WNK2 CHD7 COL18A1 ZBTB32 SETD5 YLPM1 SHARPIN AUTS2 FMN2 RERE | 8.76e-05 | 1113 | 251 | 23 | EFO_0004840 |
| Disease | cortical surface area measurement | TANC2 TET2 RIN3 CTTNBP2 MAP2 NBEAL1 SREBF1 SMARCAD1 COL22A1 RREB1 PTCH1 MBD6 FMNL2 ZNF469 TOX3 PRRC2A WNK2 ABI1 ANK3 CHD7 PHC2 EPOP KCNK10 AUTS2 RERE CUX1 | 8.95e-05 | 1345 | 251 | 26 | EFO_0010736 |
| Disease | cup-to-disc ratio measurement | ARHGAP42 CTTNBP2 RREB1 PRAG1 FMNL2 AMOTL1 RBPMS TRIB2 ANK3 LATS1 LTBP2 RERE CUX1 | 8.99e-05 | 430 | 251 | 13 | EFO_0006939 |
| Disease | Intellectual Disability | TANC2 ZNF142 CIC PRR12 PTPN23 PRRT2 RABL6 ACE2 COL18A1 MTF1 BRD4 ZNF335 EIF3F | 1.32e-04 | 447 | 251 | 13 | C3714756 |
| Disease | vital capacity | TET2 NCOA6 RIN3 MAP2 CDK12 RREB1 PTCH1 HOXA5 ZBTB7A MICAL3 MYO18B MICAL1 JADE2 RANBP3 PCLO PCDHA5 CHD7 MTF1 BRD4 SMARCA2 AUTS2 OTUD4 LTBP2 MAPKBP1 | 1.58e-04 | 1236 | 251 | 24 | EFO_0004312 |
| Disease | neuroimaging measurement, brain volume measurement | RIN3 CTTNBP2 PTCH1 PROSER3 WNK2 MPP2 GRB10 LATS1 LRCH4 SMARCA2 | 1.84e-04 | 286 | 251 | 10 | EFO_0004346, EFO_0006930 |
| Disease | mean reticulocyte volume | CHD4 REXO1 ZBTB7A ZNF469 AGFG2 RBPMS EP400 GRB10 E2F2 MLXIP RPH3A TXNDC11 TGIF1 ATF7IP BRD4 OTUD4 EIF3F EPAS1 | 1.85e-04 | 799 | 251 | 18 | EFO_0010701 |
| Disease | Spinocerebellar Ataxia Type 2 | 1.94e-04 | 34 | 251 | 4 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.94e-04 | 34 | 251 | 4 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.94e-04 | 34 | 251 | 4 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.94e-04 | 34 | 251 | 4 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.94e-04 | 34 | 251 | 4 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.94e-04 | 34 | 251 | 4 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 2.18e-04 | 35 | 251 | 4 | C0752122 | |
| Disease | neurotic disorder | 2.30e-04 | 101 | 251 | 6 | EFO_0004257 | |
| Disease | JT interval | 2.93e-04 | 248 | 251 | 9 | EFO_0007885 | |
| Disease | FEV/FEC ratio | ARHGAP42 TET2 CTTNBP2 MAP2 WDR33 SPEG RREB1 PTCH1 DENND2B PRR12 GID4 MICAL3 MMP15 WIPF2 MRTFA ARAP1 HCN1 CRTC1 MED15 YLPM1 OTUD4 LTBP2 CUX1 | 3.61e-04 | 1228 | 251 | 23 | EFO_0004713 |
| Disease | neuroticism measurement, cognitive function measurement | TET2 CTTNBP2 NBEAL1 PTCH1 SCAF1 ZBTB7A JADE2 HCN1 PCLO PCDHA5 AATK YLPM1 AUTS2 RERE | 3.85e-04 | 566 | 251 | 14 | EFO_0007660, EFO_0008354 |
| Disease | Erythema | 4.28e-04 | 4 | 251 | 2 | C0041834 | |
| Disease | alkaline phosphatase measurement | TET2 RIN3 MAP1A RREB1 PTCH1 PRAG1 DENND2B ZBTB7A MICAL3 ATF7 MINK1 ATXN1L RPH3A TXNDC11 SRRT TGIF1 ATF7IP BRD4 FMN2 LTBP2 | 4.67e-04 | 1015 | 251 | 20 | EFO_0004533 |
| Disease | neutrophil count, eosinophil count | 5.05e-04 | 213 | 251 | 8 | EFO_0004833, EFO_0004842 | |
| Disease | sexual dimorphism measurement | TET2 NCOA6 BRPF3 ZNF142 KMT2B KLF14 PTCH1 RNF214 PNPLA1 SEC16A ALPK3 WIPF2 MPP2 GRB10 PTPN23 MLXIP ZNF335 OTUD4 LTBP2 MAPKBP1 SNTA1 | 5.46e-04 | 1106 | 251 | 21 | EFO_0021796 |
| Disease | Schizophrenia | ST6GALNAC1 SREBF1 CHD4 BCL9 LILRB1 MAGI2 KLF5 SYN1 DGCR8 MAGEC1 ANK3 GRB10 XRCC1 MED15 CSF2RB PLA2G4B SMARCA2 AUTS2 | 6.07e-04 | 883 | 251 | 18 | C0036341 |
| Disease | age at menarche | TET2 KLF14 SMARCAD1 REXO1 SYCE2 MAGI2 MPP2 JADE2 CRTC1 ZBTB32 ZFHX4 SMARCA2 RERE EPAS1 | 6.19e-04 | 594 | 251 | 14 | EFO_0004703 |
| Disease | neutrophil count, basophil count | 7.03e-04 | 224 | 251 | 8 | EFO_0004833, EFO_0005090 | |
| Disease | non-syndromic X-linked intellectual disability (is_implicated_in) | 7.09e-04 | 5 | 251 | 2 | DOID:0050776 (is_implicated_in) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 7.22e-04 | 21 | 251 | 3 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | lymphocyte count | TET2 UBE4B SREBF1 KLF14 PEX13 RREB1 FMNL2 ZBTB7A ZNF469 MICAL3 SESN2 KLHL14 MRTFA RBPMS TRIB2 AKIRIN1 MINK1 E2F2 CHD7 RPH3A CD6 AUTS2 LTBP2 RERE NEURL4 | 7.72e-04 | 1464 | 251 | 25 | EFO_0004587 |
| Disease | neutrophil count | TET2 RIN3 WDR33 RREB1 BCL9 ISM2 DENND2B CIC ATXN1 FAM186A KLF5 NBEAL2 WIPF2 ATF7 RBPMS TRIB2 JADE2 E2F2 PCDHA5 CHD7 TGIF1 AATK RERE HYDIN | 7.82e-04 | 1382 | 251 | 24 | EFO_0004833 |
| Disease | schizophrenia, intelligence, self reported educational attainment | TET2 ATXN1 MRTFA MAPK1IP1L HCN1 CRTC1 ATF7IP BARHL2 SMARCA2 RERE | 8.18e-04 | 346 | 251 | 10 | EFO_0004337, EFO_0004784, MONDO_0005090 |
| Disease | irritable bowel syndrome | 9.20e-04 | 131 | 251 | 6 | EFO_0000555 | |
| Disease | eosinophil count | TET2 RIN3 SREBF1 TNFRSF4 ZBTB7A ATXN1 SEC16A SESN2 WIPF2 RBPMS TRIB2 AKIRIN1 GRB10 E2F2 CHD7 RPH3A TXNDC11 PHC2 CSF2RB MTF1 ATF7IP SHARPIN LTBP2 RERE CUX1 | 9.71e-04 | 1488 | 251 | 25 | EFO_0004842 |
| Disease | body fat percentage | RIN3 KLF14 SCYL1 MAGI2 MMP15 PRRC2A PRRC2B TRIB2 CRTC1 YLPM1 AUTS2 RERE | 1.05e-03 | 488 | 251 | 12 | EFO_0007800 |
| Disease | asphyxia neonatorum (biomarker_via_orthology) | 1.06e-03 | 6 | 251 | 2 | DOID:11088 (biomarker_via_orthology) | |
| Disease | IGF-like family receptor 1 measurement | 1.06e-03 | 6 | 251 | 2 | EFO_0801687 | |
| Disease | hematocrit | BRPF3 NBEAL1 SREBF1 PFAS RREB1 DENND2B PRR12 PWWP2A PNPLA1 TOX3 AGFG2 EMC10 NYAP1 TRIB2 JADE2 CRTC1 ANKRD17 HYDIN EPAS1 | 1.13e-03 | 1011 | 251 | 19 | EFO_0004348 |
| Disease | myeloid white cell count | TET2 RIN3 SH3BP1 SREBF1 RREB1 BCL9 FMNL2 DENND2B CIC ZBTB7A ATXN1 WIPF2 ATF7 RBPMS TRIB2 E2F2 CHD7 RERE | 1.19e-03 | 937 | 251 | 18 | EFO_0007988 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.20e-03 | 364 | 251 | 10 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | household income | 1.25e-03 | 304 | 251 | 9 | EFO_0009695 | |
| Disease | free androgen index | TET2 UBE4B RREB1 ZNF469 CHD7 ZFHX4 SMARCA2 RIMBP2 EPAS1 CUX1 | 1.47e-03 | 374 | 251 | 10 | EFO_0007005 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TET2 CTTNBP2 SCAF4 MAGI2 PRRC2B MPP2 ABI1 JADE2 HCN1 MINK1 CHD7 PHC2 AATK BARHL2 AUTS2 CUX1 | 1.49e-03 | 801 | 251 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | granulocyte count | 1.57e-03 | 254 | 251 | 8 | EFO_0007987 | |
| Disease | reticulocyte count | ARHGAP42 NCOA6 KLF14 RREB1 DENND2B SYCE2 ZNF469 ATXN1 WDR20 NYAP1 ARID3A PLEKHA4 LARP1 E2F2 ATXN1L RPH3A PALM3 OTUD4 CUX1 | 1.64e-03 | 1045 | 251 | 19 | EFO_0007986 |
| Disease | severe acute respiratory syndrome, COVID-19 | RIN3 REXO1 MAGI2 TOX3 P3H3 GRB10 CRTC1 MED15 AUTS2 RIMBP2 LTBP2 | 1.67e-03 | 447 | 251 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | Psychotic Disorders | 1.75e-03 | 101 | 251 | 5 | C0033975 | |
| Disease | cesarean section, anxiety | 1.95e-03 | 8 | 251 | 2 | EFO_0005230, EFO_0009636 | |
| Disease | holoprosencephaly (is_implicated_in) | 1.95e-03 | 8 | 251 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Cornelia De Lange Syndrome | 1.95e-03 | 8 | 251 | 2 | C0270972 | |
| Disease | prostate cancer (is_marker_for) | 2.24e-03 | 156 | 251 | 6 | DOID:10283 (is_marker_for) | |
| Disease | Epilepsy | 2.44e-03 | 109 | 251 | 5 | C0014544 | |
| Disease | influenza A severity measurement | 2.49e-03 | 9 | 251 | 2 | EFO_0007743 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.49e-03 | 9 | 251 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 2.51e-03 | 32 | 251 | 3 | C0345958 | |
| Disease | heart conduction disease (implicated_via_orthology) | 2.51e-03 | 32 | 251 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | TET2 CDK12 SMARCAD1 ACSL4 ZBTB7A FAF2 JADE2 CHD7 XRCC1 BCAR1 BRD4 SPEN ZMYM3 | 2.55e-03 | 616 | 251 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | TET2 CDK12 SMARCAD1 ACSL4 ZBTB7A FAF2 JADE2 CHD7 XRCC1 BCAR1 BRD4 SPEN ZMYM3 | 2.55e-03 | 616 | 251 | 13 | C0376358 |
| Disease | Seizures | 2.74e-03 | 218 | 251 | 7 | C0036572 | |
| Disease | Holoprosencephaly sequence | 3.10e-03 | 10 | 251 | 2 | cv:C0079541 | |
| Disease | forced expiratory volume | TET2 NCOA6 RIN3 CDK12 PTCH1 BCL9 HOXA5 MICAL3 PRRC2B MICAL1 LARP1 MED15 EPOP SMARCA2 OTUD4 | 3.31e-03 | 789 | 251 | 15 | EFO_0004314 |
| Disease | Endometrial Carcinoma | 3.34e-03 | 72 | 251 | 4 | C0476089 | |
| Disease | platelet crit | TET2 RIN3 MAP1A RREB1 DENND2B PWWP2A KCND1 WDR20 NOTCH3 RBPMS TRIB2 SOCS3 YLPM1 OTUD4 FMN2 RERE CUX1 | 3.43e-03 | 952 | 251 | 17 | EFO_0007985 |
| Disease | parental longevity | ARHGAP42 CTTNBP2 COL22A1 SORCS1 IQCE TRIB2 BICRA PCLO TMTC1 YLPM1 SMARCA2 | 3.59e-03 | 494 | 251 | 11 | EFO_0007796 |
| Disease | PR interval | OBSCN MAGI2 ZNF469 CASKIN2 ALPK3 WIPF2 RBPMS HCN1 MINK1 TGIF1 EPAS1 | 3.64e-03 | 495 | 251 | 11 | EFO_0004462 |
| Disease | reticulocyte measurement | ARHGAP42 KLF14 PFAS RREB1 DENND2B SYCE2 ZNF469 WIZ ATXN1 WDR20 NYAP1 ARID3A PLEKHA4 LARP1 E2F2 ATXN1L BRD4 CUX1 | 4.14e-03 | 1053 | 251 | 18 | EFO_0010700 |
| Disease | Squamous cell carcinoma | 4.24e-03 | 124 | 251 | 5 | C0007137 | |
| Disease | chronic musculoskeletal pain | 4.50e-03 | 12 | 251 | 2 | EFO_0022195 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 4.50e-03 | 12 | 251 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Mitral valve prolapse, response to surgery | 4.50e-03 | 12 | 251 | 2 | EFO_0009951, HP_0001634 | |
| Disease | Neurobehavioral Manifestations | 4.50e-03 | 12 | 251 | 2 | C0525041 | |
| Disease | Glioblastoma | 4.66e-03 | 79 | 251 | 4 | C0017636 | |
| Disease | cervical cancer | 4.76e-03 | 40 | 251 | 3 | MONDO_0002974 | |
| Disease | coffee consumption measurement | 4.78e-03 | 182 | 251 | 6 | EFO_0006781 | |
| Disease | plasma beta-amyloid 1-42 measurement | 5.28e-03 | 13 | 251 | 2 | EFO_0005660 | |
| Disease | colorectal cancer, endometrial neoplasm | 5.47e-03 | 42 | 251 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | beta-nerve growth factor measurement | 5.47e-03 | 42 | 251 | 3 | EFO_0008035 | |
| Disease | Giant Cell Glioblastoma | 5.80e-03 | 84 | 251 | 4 | C0334588 | |
| Disease | body weight | TET2 NBEAL1 NDN PTCH1 MEX3A ITIH6 ARAP1 MPP2 JADE2 GRB10 CRTC1 CHD7 MON1B RPH3A TXNDC11 PHC2 AATK AUTS2 LTBP2 EPAS1 | 5.83e-03 | 1261 | 251 | 20 | EFO_0004338 |
| Disease | electrocardiography | ARHGAP42 SPEG OBSCN SCYL1 HMCN2 PROB1 MYO18B MMP15 TRIB2 HCN1 EPAS1 | 6.01e-03 | 530 | 251 | 11 | EFO_0004327 |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 6.13e-03 | 14 | 251 | 2 | EFO_0004736, GO_0031427 | |
| Disease | inositol measurement | 6.13e-03 | 14 | 251 | 2 | EFO_0010504 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 6.13e-03 | 14 | 251 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 6.13e-03 | 14 | 251 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | chronic obstructive pulmonary disease | TET2 RIN3 SPEG RREB1 PTCH1 BCL9 MICAL3 MMP15 MPP2 CRTC1 TMTC1 EPOP OTUD4 | 6.37e-03 | 688 | 251 | 13 | EFO_0000341 |
| Disease | Drugs used in diabetes use measurement | 6.41e-03 | 255 | 251 | 7 | EFO_0009924 | |
| Disease | white matter microstructure measurement | CTTNBP2 KMT2B NBEAL1 PTCH1 ANKHD1 SCAF1 PROSER3 ROBO3 ZBTB32 | 6.49e-03 | 390 | 251 | 9 | EFO_0005674 |
| Disease | rheumatoid arthritis | RIN3 KMT2B CDK12 ARAP1 VPS37C ARID3A TXNDC11 CSF2RB MTF1 SCAF11 | 6.52e-03 | 462 | 251 | 10 | EFO_0000685 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.63e-03 | 45 | 251 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | mean corpuscular hemoglobin concentration | CDK12 PFAS RREB1 SYCE2 ATXN1 SEC16A ARHGEF37 ATMIN RBPMS EP400 LARP1 E2F2 TGIF1 BRD4 SHARPIN OTUD4 EIF3F CAPN15 | 6.72e-03 | 1105 | 251 | 18 | EFO_0004528 |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 6.82e-03 | 88 | 251 | 4 | EFO_0000341, EFO_0006527 | |
| Disease | Unipolar Depression | 6.95e-03 | 259 | 251 | 7 | C0041696 | |
| Disease | P wave duration | 7.03e-03 | 15 | 251 | 2 | EFO_0005094 | |
| Disease | Alobar Holoprosencephaly | 7.03e-03 | 15 | 251 | 2 | C0431363 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 7.03e-03 | 15 | 251 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 7.47e-03 | 142 | 251 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Colorectal Carcinoma | TET2 MAP2 OBSCN OTOP2 DNALI1 ACSL4 KLF5 SESN2 STAM XRCC1 TENM1 EP300 CUX1 | 7.48e-03 | 702 | 251 | 13 | C0009402 |
| Disease | unipolar depression | CTTNBP2 PTCH1 MAGI2 ALPK3 ARHGEF37 PRRC2A MICAL1 TRIB2 PCLO PCDHA5 CHD7 MON1B TMTC1 YLPM1 SMARCA2 AUTS2 LTBP2 RERE EIF3F | 7.63e-03 | 1206 | 251 | 19 | EFO_0003761 |
| Disease | C-reactive protein measurement | NCOA6 MAP1A UBE4B RREB1 PRAG1 SCAF4 ZNF469 SEC16A MICAL3 ARAP1 ANK3 SOCS3 CHD7 LATS1 SETD5 SCAF11 SERPINA10 RERE CUX1 | 7.63e-03 | 1206 | 251 | 19 | EFO_0004458 |
| Disease | non-melanoma skin carcinoma | 7.84e-03 | 265 | 251 | 7 | EFO_0009260 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TQTPPQSLQQPAPPG | 51 | Q9H9L7 | |
| NPENLGIPPSRPTPS | 256 | O60488 | |
| PPSIGAQQPPATTIP | 846 | Q09472 | |
| APPSSQLPIPPSQPA | 641 | Q96L91 | |
| PLQTPGAPNPAQVPA | 3116 | Q96L91 | |
| PLPQPPSAISPGENS | 781 | Q99814 | |
| APTPAPTPTPAVAQA | 1011 | Q4VCS5 | |
| NSSPAPPQPAPGKVE | 1081 | Q9NYV4 | |
| QPANAASTNPPPPET | 36 | O60885 | |
| ASTNPPPPETSNPNK | 41 | O60885 | |
| PGPSPQFQSPPAKQT | 131 | P56945 | |
| VQPPPTTQPLLPGSE | 481 | A1IGU5 | |
| RQPVPASQGPTNPAP | 386 | A6NKF2 | |
| VPRPAEQTEPPPSGT | 1366 | P39880 | |
| EAISGVPTPPAIPPQ | 676 | Q9Y3L3 | |
| GKAPPQASVQVPTPP | 716 | Q96L96 | |
| VPGTPPTPTQVLFQP | 316 | Q8IV13 | |
| IAVPTPSPPTIGPEN | 261 | Q8IZP0 | |
| PPPQPPSLNKTVSNG | 786 | Q9ULD4 | |
| GAPQPPPAASPSQQL | 416 | Q8IY63 | |
| DAPSPAQPQVSPAQP | 301 | P17544 | |
| PPGSVSQEPRPPLQQ | 2111 | O75179 | |
| PGLITPGSPPPAQQN | 231 | P54253 | |
| PREQSPPPPLQTSSG | 31 | Q8WYQ5 | |
| SPQNPQDPSPDTSPP | 76 | P78524 | |
| TPPTRNIPSPGQLDP | 2551 | Q9P2D1 | |
| GQRTTTPPPSQIPDP | 716 | Q6ZS30 | |
| ASASTPPPPAPEAQL | 71 | Q9H6Z4 | |
| VGTPNPSTPLPNTVP | 111 | Q93062 | |
| PQPEIGPPTFSSPLV | 781 | Q01804 | |
| GPPTFSSPLVIPPSQ | 786 | Q01804 | |
| SSSPGTPQPAPQLPL | 311 | Q3YEC7 | |
| EPPSVPGLPDQSSPV | 571 | Q6IPM2 | |
| PGLPDQSSPVPRVPS | 576 | Q6IPM2 | |
| PLPVNPTDPAVTGPD | 341 | Q9H3S7 | |
| EPPGLTQLSPGAPPQ | 21 | Q8IVL6 | |
| PCPSPIPTPEQGLSQ | 186 | A6NDB9 | |
| QGAPAPAPASQEPLP | 471 | O75427 | |
| QPPSPSPPPQSEALS | 56 | Q7L1V2 | |
| QPPVPEAAQPSPSAG | 256 | O75808 | |
| ETKPPPSGPQPTSQA | 611 | O43747 | |
| SPGPLPPLQFSPQGS | 301 | O75106 | |
| TPELPPPPAAGNTSV | 101 | P30203 | |
| PASTTGPTTPQPGQP | 1366 | Q6W4X9 | |
| GPTTPQPGQPTRPTA | 1371 | Q6W4X9 | |
| ISQPPTPPTGQPVRE | 1066 | Q6PKG0 | |
| PGSLPPEPPSVSQAF | 161 | Q96DN6 | |
| LAATLDPPSGTPPQP | 681 | Q96DN6 | |
| GLTVPAASQQPPAPS | 381 | Q5VYV0 | |
| IPTPPANTPDESQPS | 601 | Q9NSA2 | |
| PEARTPVSPGSPQPQ | 1231 | Q7RTP6 | |
| ASTPTPGQAGPQPPA | 291 | Q9H2Z4 | |
| PPPSPSTSVGPSEQI | 271 | Q96LI6 | |
| EPQTPPAQKGTVPLP | 501 | P78559 | |
| QQSTNPAPGILGPPP | 346 | P43243 | |
| PQSFPESPQSPPEGP | 756 | O60732 | |
| ESPQSPPEGPAQSPL | 761 | O60732 | |
| PPEGPAQSPLQRPVS | 766 | O60732 | |
| ESPQSPPEGPAQSPL | 796 | O60732 | |
| PPEGPAQSPLQSPVS | 801 | O60732 | |
| PVTTQNPPGAPPNVL | 281 | Q9Y5V3 | |
| AQGPTPEPPLASPQT | 156 | Q96JG8 | |
| QPSPATPNSPIAQPA | 1041 | Q86UL8 | |
| PQPIQTVQPSPFPEG | 521 | O95835 | |
| PPQLVPAPNVTVSPG | 516 | Q8NDA2 | |
| PPAGASPVLTPQESQ | 246 | P0C7T5 | |
| PDGQPQPTQPLPTVT | 306 | P51511 | |
| LNGSLVPVPPTTPAP | 716 | B1AK53 | |
| VPVPPTTPAPGVQLD | 721 | B1AK53 | |
| APTGEQATPAPPQPS | 126 | Q5VYM1 | |
| LPPLEGPPAQASPSS | 106 | Q9NQC1 | |
| PGNATPPRTPEVTPL | 91 | Q6H9L7 | |
| PSSEQPGPKALAQPP | 381 | Q9Y6V0 | |
| PSQTPGSAPPPQAQG | 786 | Q8WUM4 | |
| VTPPQDQVPLNPPGT | 581 | Q9ULL4 | |
| PEPQGPLPVQPTADT | 46 | P39060 | |
| SAQSEPSPAPPAQPQ | 161 | P20719 | |
| PGPQLLNPGTPVSPQ | 2191 | Q9UM47 | |
| PLSTQPPQGPPEAQL | 336 | Q8WXX7 | |
| TGTPERAQPPPPQDL | 241 | P0CG43 | |
| FSVPSPGPLNTPVNP | 501 | Q96RN5 | |
| TPPPGLSPLSPQQQV | 391 | Q8N8W4 | |
| APASTVPGPTLAPQP | 206 | Q9UQV4 | |
| PEPGVPLTPPSQHQE | 676 | Q8TDZ2 | |
| LPPAPPLANGSQPSQ | 2136 | Q9UMN6 | |
| SATNGQPPAPAPTPT | 26 | P57789 | |
| TAAVELTVGPPPPPQ | 376 | Q9BTN0 | |
| LTVGPPPPPQLANST | 381 | Q9BTN0 | |
| TPPPSPGLDPTFSNQ | 141 | Q14168 | |
| PGLDPTFSNQPVPPD | 146 | Q14168 | |
| QGIPFPPISPSPEEQ | 661 | P0C869 | |
| PQGPTSTDNPRQPNP | 776 | Q9Y5H7 | |
| AQPPRTQTPPLGQTP | 501 | P78344 | |
| GVEPQPPAAPAVTPA | 336 | Q6ZMM2 | |
| LPQPEPSSLPAQGVP | 1036 | Q8WXE0 | |
| PSSLPAQGVPTPLAP | 1041 | Q8WXE0 | |
| QGPSLPATPVFVPVP | 546 | Q7Z6E9 | |
| PPNPGLVSPSPSDQR | 461 | Q7RTS6 | |
| PPPFEQTFPSLQPGA | 46 | P14652 | |
| PPPPINTQQPGVATS | 106 | Q8IVV7 | |
| LVPSSPFLGQPQAPP | 7071 | Q5VST9 | |
| GQGLPSLPPNTSPFP | 231 | Q9BRQ0 | |
| VSPTPLANPPVPGSF | 1376 | Q14686 | |
| APVPPNALSSSPAPN | 1711 | Q14686 | |
| QPTDFGPSEPPLSVP | 411 | Q9HAP2 | |
| PVNSPAPQDTTAAPP | 156 | Q8TAX7 | |
| VPDQPEAPQPGPNTT | 41 | Q7Z6L0 | |
| PAGATQQPAVPAPPA | 51 | O43313 | |
| PSPQPQTPGSSTPKN | 751 | O60741 | |
| PAASDLPTEQPPSPQ | 556 | P32927 | |
| PQPSGSQEPRDPQSP | 971 | Q4G0P3 | |
| QQPPPQEEPGTPSSS | 96 | Q9P2G3 | |
| ASSVPAPAPTPQQAP | 346 | Q14209 | |
| AQAPAQTPAPALPGP | 66 | O00303 | |
| RGPQPPPLAVTVPSS | 406 | Q6UUV9 | |
| TVPSSLPQSPPENPG | 416 | Q6UUV9 | |
| LPSNAAPPTAQTPGI | 401 | Q8WZ74 | |
| DEPNLVPGPQVPPAS | 61 | Q96PV7 | |
| PQRGPAASPPQEPSS | 166 | A6NHQ4 | |
| NESVPDSPARTPQPP | 301 | Q86XJ1 | |
| PPPTASQPASVNIPG | 971 | O00512 | |
| PEPLPLSTPSAGTPQ | 286 | Q86UU0 | |
| LSTPSAGTPQSQPPP | 291 | Q86UU0 | |
| PPAPPALESDNPSQP | 246 | Q5T0F9 | |
| GIQPTLGPPNQPPVS | 726 | Q9BYF1 | |
| RVQPPSPVPPGADVS | 3301 | Q12955 | |
| PPQRPPTPGSEQIGF | 456 | Q8NFW1 | |
| SQQPPPPAAAPTQSL | 91 | Q9NY43 | |
| PPLPPSSDTPETVQN | 531 | Q96PY5 | |
| QQPGPSGSAPQPPKT | 36 | O14645 | |
| IQPAPPLQPSGVPTS | 1006 | Q6VMQ6 | |
| QSPPAPQSPPAGTLS | 266 | Q14767 | |
| SSLFQGPENLQPPPP | 1376 | O60336 | |
| NSSRPTPEGSPPNLP | 971 | Q6UXX5 | |
| ATGPSVTNPFQPAPP | 511 | Q9Y6I3 | |
| ASVPQLPQVPAPSPG | 61 | Q8TD94 | |
| PPVLTPGSLPPSQAA | 151 | Q13322 | |
| TSPTPAPDNPPQAPT | 436 | Q6PII3 | |
| GPPFEGQSQVQPPPS | 66 | Q16610 | |
| QLQPPTTAPGPETAA | 186 | Q5UCC4 | |
| PQAPPSPGQLPISRA | 1816 | A6NE01 | |
| PTPQAAAPPQATTPQ | 651 | Q9NZM4 | |
| AAPPQATTPQPSPGL | 656 | Q9NZM4 | |
| PTPSTPGDTQPNTPA | 1541 | Q14839 | |
| QQPPSPGGLPVSEAP | 291 | Q9NZ56 | |
| LPSTAIPQPPPLQGT | 891 | Q9NZ56 | |
| PAAPTNLPTPPVTQP | 811 | O95104 | |
| VATPTSVSQGLPPPP | 1266 | Q99590 | |
| QAAAQTPPRPGPPSA | 186 | P51172 | |
| LPTSDSSPEPQQPPE | 411 | Q9UPN4 | |
| RTQPPAPPGVSPQAL | 66 | Q8N4B5 | |
| QITVLPPEPGFSPPT | 201 | Q96JN8 | |
| PVPEPLPEGNNQVSP | 691 | Q96JN8 | |
| PGAASSPLQQVPAPP | 361 | Q8TB24 | |
| NNPSAPSSVPSGLPP | 41 | Q8NDC0 | |
| IPQASPGPPGPLSQT | 551 | Q8N4C8 | |
| RANGPPPLTATSPPQ | 276 | Q6ZVC0 | |
| SPATQPQFPLPPGAQ | 141 | Q96NZ1 | |
| PTSAPQQPASQAAPP | 511 | P17600 | |
| PPPAKPASPAQVQSS | 351 | Q8N1G1 | |
| QGPDTAPRPSPPQEE | 461 | Q8N1F8 | |
| PAPQAPTPPSEQSSP | 226 | P58004 | |
| TLPAGPPAPPQDVTV | 481 | O15034 | |
| GQQSAPQADEPPLPP | 56 | Q96N64 | |
| PAAPGPSDQPSQELP | 71 | Q9NNX9 | |
| SRPAPGSVQSPAPPQ | 276 | Q9Y2J0 | |
| PASPLQRQPSSPGPT | 191 | Q13424 | |
| PAAPGPSDQPSQELP | 71 | Q9H321 | |
| PAAPGPSDQPSQELP | 71 | O14598 | |
| APPRPQTPENGPEAS | 136 | O15240 | |
| SVPQPAPGQPSPVLQ | 306 | P51531 | |
| PEATPQPSQPGPSSP | 21 | Q9H4L7 | |
| PGPPSAQSSPIDAQP | 1076 | O43426 | |
| GQQTIPLIPSPFGPP | 11 | Q7Z3H4 | |
| TNIPQRPTPEGVPAP | 596 | Q96KG9 | |
| LPSVPSPSQEGAPLP | 796 | Q6ZMQ8 | |
| ATEPPPSQEGPSPAV | 626 | Q8NHL6 | |
| PDPSIPLPQPQSRSG | 576 | A6NI28 | |
| PAFQPPLPPTDGSTV | 521 | Q68EM7 | |
| GLEQPSHTPPQTPTP | 746 | Q68EM7 | |
| QTPTPPSTPPLGKQN | 756 | Q68EM7 | |
| QETPPPRSPPVANSG | 716 | Q9H4M7 | |
| SAPPPAPSLGPGSQQ | 441 | Q14872 | |
| PSPQAPDGPSLQLPA | 661 | Q14872 | |
| VSSPSQTPRPQPGPI | 2011 | Q6ZNJ1 | |
| QPGLSALTTPPPQAS | 486 | Q9H6K5 | |
| PPQASPSPSPPSLQA | 496 | Q9H6K5 | |
| GVPSVFNPPPSRPLQ | 56 | Q96CS3 | |
| NGPPQPGAPSSSPTV | 16 | P55055 | |
| QPTSQPPVPQLPEGE | 246 | P98174 | |
| PEEPAQAPPAQSTPT | 546 | P48634 | |
| PPQPVTLGAVPAPQA | 681 | P48634 | |
| PANGLNRLPTPSPEP | 1186 | Q13635 | |
| PPPPNSGSKSPQLAT | 856 | Q9C0A6 | |
| PQATPPPAPFQSPTT | 231 | Q9NSC7 | |
| AQPAEPQPLGTQVPP | 1276 | Q13796 | |
| GPQPAASSLPSPLQP | 336 | Q9H0F6 | |
| GEPRPQAPPSLPTQG | 786 | Q96T21 | |
| SPGNLPQPESFSPPS | 1881 | Q9HCD6 | |
| QPSPAAPAPPTSTQD | 226 | Q9UKZ4 | |
| VPPPILPRPSQQTGS | 51 | Q92968 | |
| PASPAPAQAQTPTPA | 256 | Q2NL68 | |
| PAQAQTPTPAPAPAS | 261 | Q2NL68 | |
| FQVGSPEALAPPPPA | 371 | Q2NL68 | |
| TVAPGPVQSPLPLSP | 1301 | O95785 | |
| NSVTTPGNSVPPPLP | 416 | Q8TBZ3 | |
| PGNSVPPPLPRSNSL | 421 | Q8TBZ3 | |
| TPESQPDTPPGTPLV | 111 | Q96T60 | |
| ETTNIVAPPPPSNPG | 1456 | Q13017 | |
| PLPSSPAQPPGLTQS | 996 | Q9P2R6 | |
| ASSTSGPQPPPPQSL | 71 | Q15714 | |
| PPELSPIPASPGQAA | 426 | Q9H093 | |
| QDPPFSPPANGLLSP | 171 | Q9ULL5 | |
| SVPARGLQPQPPATP | 1316 | Q9ULL5 | |
| SPPRPGNSQPPDVFV | 181 | Q6PIF2 | |
| SLPPSPGPQALGSPQ | 951 | E7EW31 | |
| AQQPAPAPAPLGTPV | 561 | Q969V6 | |
| PGSQVLPPPPTTLNG | 166 | O94855 | |
| TGGLFNTPPPTPPEQ | 176 | Q9GZN2 | |
| QAAPSPLSPPQPAPT | 91 | P36956 | |
| EPGTPPLPTSLPSQN | 541 | Q9BXP5 | |
| PLPSTNPFQPNGLAP | 376 | O95081 | |
| AQPPAPTPTSAPNKG | 536 | Q99856 | |
| SEEPLSTLPQGPPQP | 191 | Q96P48 | |
| VTNPVTLTPPQGPPA | 2161 | Q8IWZ3 | |
| SPPFSVPVQNGAQPP | 946 | Q96RK0 | |
| PPSPGPSPDVQLATL | 286 | Q9Y679 | |
| PPPQDSSKPVVAQGP | 101 | P23246 | |
| NTQSGLFNTPPPTPP | 356 | Q15583 | |
| PALSQPSQPSSPLPG | 491 | Q8ND24 | |
| PGGLPVPTSPNIQPS | 501 | Q8IXK0 | |
| SDPPQASTAQPQPQP | 2391 | Q86UP3 | |
| TTPPTSPGNVPPDLS | 356 | Q92574 | |
| QQLPPPPAPAGSGSS | 231 | Q9UPR6 | |
| SGQSVAPIPQPPAES | 21 | Q13432 | |
| PRSPQQPGSPQPSSL | 251 | Q8IUR5 | |
| PAAPGPSDQPSQELP | 71 | Q9H322 | |
| PEGEPLQPPQPVQST | 3346 | Q96T58 | |
| PSAPQTLPDGPLASP | 1951 | O15027 | |
| ATTPSDAPQPPAPQP | 2196 | Q15772 | |
| QQASPGCISPSLPPP | 531 | Q92766 | |
| APAATPEPPAQPLQG | 996 | Q92766 | |
| APTAAPAAQTPQPPT | 91 | A1L020 | |
| PAAQTPQPPTAPKGA | 96 | A1L020 | |
| RPDAQPTQPTPAPGT | 321 | Q9H7N4 | |
| PTQPTPAPGTPPQVD | 326 | Q9H7N4 | |
| PAASATPTAQPLPQP | 421 | Q9H7N4 | |
| PNLGSPSPPETPNLS | 41 | Q92519 | |
| SNPTTPLPNLPVGPG | 701 | Q5VZP5 | |
| NGQGDAPPTPLPTPV | 611 | O15067 | |
| EPSSPPGAPSQPVVT | 551 | Q96MS0 | |
| TTPLTSPQRENPPGP | 26 | O95155 | |
| SPQRENPPGPPIAAS | 31 | O95155 | |
| QPPPAATELGPSTSP | 331 | Q658T7 | |
| LPGPPPGQPEATQLT | 1791 | P53804 | |
| RIPPPGSQPPVLNTS | 2111 | Q5JSZ5 | |
| LQVPGNTLPSPPPAA | 161 | Q96G79 | |
| EVPEQPSAQPLPGSP | 146 | O14543 | |
| STLPQPGGSQQPPQP | 516 | Q92783 | |
| TSPIPAIGSPQPASQ | 541 | O15405 | |
| TEDVSPSGPQQPPPL | 801 | Q86YV5 | |
| PAAPGPSDQPSQELP | 71 | Q9H320 | |
| GIPPQLTAAPVPPAS | 641 | P49750 | |
| ANLPPSPPPSPASEQ | 131 | P11137 | |
| PVVESRSGQESPPPP | 1206 | Q8IUG5 | |
| PPAPPSPSIQGQSVL | 126 | Q96SK2 | |
| PPATQPQETQGPPAR | 171 | P43489 | |
| GLAPSPQSPETPAPQ | 21 | Q9UK55 | |
| GSPQTPPGRSPLQAP | 91 | Q96JG9 | |
| PAPGPPQSRGTSPLQ | 206 | Q96JG9 | |
| QEEAEPTPSPPSPNR | 2021 | Q96JG9 | |
| QPEPSATPQLPGSSP | 951 | Q6PKC3 | |
| ATPQLPGSSPPPANV | 956 | Q6PKC3 | |
| FQPGRQIPPPQTPST | 96 | Q5W150 | |
| QAAGPSSPQKPPTPE | 441 | P18887 | |
| PTPGSLPQGPAQLSP | 316 | Q9Y2Y4 | |
| PTPPPDSEPSNQLSA | 621 | P52746 | |
| RQPPGVPNGPSSPTN | 256 | Q8TF74 | |
| QIQPPPSSGTPLLGP | 571 | Q9C0J8 | |
| LGPTVPPQPPSALES | 1556 | Q9Y3S1 | |
| PQPSGTPTPSQPSAA | 41 | Q9BVT8 | |
| VALPSPPSPSTQPGD | 1126 | Q8WY21 | |
| IEGKPEAPPSQSPNP | 451 | Q6N021 | |
| SPGPPEIPPEATTFQ | 746 | Q9H4Z2 | |
| GALPPAPFPVVSQPS | 221 | A5D8V6 | |
| QLPSFPGQPQPSVPL | 316 | A5D8V6 | |
| NIKEEPPSPGTPPQS | 506 | Q8NAF0 | |
| TQPSQEFVPPATPPA | 1791 | Q68DK2 | |
| SVPTQGPSPGSLPQP | 106 | Q9H347 | |
| PAVPTQQPADPSTPE | 501 | O15231 | |
| PELPGPSVTPVPQLS | 436 | P18583 | |
| QGQPQSPNAPPSPSV | 181 | Q14202 | |
| LFPPPVAPPAATQNG | 256 | O95365 | |
| ALPGPAEASQPQPPS | 156 | A6NP61 | |
| QAPQPAQPPATGPRL | 66 | Q13887 | |
| VPSEVVPNPKGTPSP | 191 | E9PAV3 | |
| SPGSAPVPGTQPPLQ | 31 | Q96HR8 | |
| GVPPSATLAEPQSPP | 31 | Q99608 | |
| PQSPPLGPTAAPQAA | 41 | Q99608 | |
| LGPTAAPQAAPPPQA | 46 | Q99608 |